{"text_format":"3","workbook":"xls","n_sheets":12,"sheets":["2014機構名單(簡)","研習機構(公告)-2014","2014年新加入者","關鍵領域2014","NIH研習單位資訊","Caltech","Argonne","哥倫比亞","NIH NIDAIRP","NIH-NINDS","NIH-NCI","Harvard University"],"not_rendered":{"external_links":1,"defined_names":5,"comments":5},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"2014機構名單(簡)","index":0,"n_rows":54,"n_cols":5,"rows_kept":54,"flags":["formulas_cached_only"]}
["洲別","國家","公告機構數","研習大學或國家級研究中心","(詳細內容如後附13頁)"]
["亞洲 (7)","澳大利亞",2,"Monash University","(新單位)"]
[{"$nulls":3},"The University of Queensland"]
[null,"韓國",1,"Korea University "]
[null,"日本",4,"University of Tokyo"]
[{"$nulls":3},"Tohoku University"]
[{"$nulls":3},"Kyoto University","(加入新實驗室)"]
[{"$nulls":3},"National Institute for Materials Science (NIMS)","(加入新實驗室)"]
["歐洲 (21)","奧地利",1,"Universität Wien"]
[null,"比利時",1,"Interuniversity MicroElectronics Center (IMEC)"]
[null,"丹麥",1,"Aarhus University"]
[null,"法國",4,"國家衛生及醫學研究院 INSERM"]
[{"$nulls":3},"法國國家科學研究中心 CNRS"]
[{"$nulls":3},"巴斯德研究院 Institut Pasteur"]
[{"$nulls":3},"European Synchrotron Radiation Facility (ESRF)"]
[null,"德國",5,"達姆施塔特高等資訊安全研究中心 (CASED)"]
[{"$nulls":3},"癌症研究中心 (DKFZ)"]
[{"$nulls":3},"Juelich研究中心"]
[{"$nulls":3},"Max Delbrück Center for Molecular Medicine (MDC)"]
[{"$nulls":3},"University Medical Center Freiburg","(新單位)"]
[null,"荷蘭",1,"Erasmus University Rotterdam","(新單位)"]
[null,"俄羅斯",1,"Kurchatov Insitute"]
[null,"瑞士",2,"Ecole Polytechnique Fédérale de Lausanne (EPFL)"]
[{"$nulls":3},"蘇黎世聯邦理工學院\nEidgenössische Technische Hochschule Zürich (ETH)","(新單位)"]
[null,"英國",5,"The Imperial College of Science, Technology and Medicine"]
[{"$nulls":3},"University of Cambridge"]
[{"$nulls":3},"University College London (UCL)"]
[{"$nulls":3},"University of Edinburgh"]
[{"$nulls":3},"University of Southampton","(新單位)"]
["美洲 (21)","加拿大",4,"Canadian Light Source "]
[{"$nulls":3},"The University of Britich Columbia  "]
[{"$nulls":3},"University of Ottawa","(新單位)"]
[{"$nulls":3},"University of Toronto (incl. UHN)"]
[null,"美國",17,"Argonne National Laboratory"]
[{"$nulls":3},"National Institutes of Health (NIH)","(加入新研究所)"]
[{"$nulls":3},"Columbia University"]
[{"$nulls":3},"Harvard University"]
[{"$nulls":3},"Johns Hopkins University"]
[{"$nulls":3},"MIT"]
[{"$nulls":3},"Baylor College of Medicine","(加入新實驗室)"]
[{"$nulls":3},"National Center for Atmospheric Research (NCAR)"]
[{"$nulls":3},"Rice University"]
[{"$nulls":3},"The University of Texas Austin"]
[{"$nulls":3},"University of Texas MD Cancer Center"]
[{"$nulls":3},"The University of Texas Southwestern Medical Center"]
[{"$nulls":3},"California Institute of Technology"]
[{"$nulls":3},"University of Southern California","(新單位)"]
[{"$nulls":3},"University of California (UCLA, UC San Diego, UC Berkeley and UC San Francisco)","(加入新實驗室)"]
[{"$nulls":3},"Lawrence Berkeley National Laboratory"]
[{"$nulls":3},"Stanford University","(加入新實驗室)"]
["總計",null,49]
[]
[null,"備註:","酒紅字列出者，表示為2014年新增之機構，計7所"]
[null,null,"紫字列出者，表示2014年有新加入之實驗室"]

{"sheet":"研習機構(公告)-2014","index":1,"n_rows":97,"n_cols":9,"rows_kept":97,"merged":[[0,0,0,8],[5,0,6,0],[5,1,6,1],[5,2,6,2],[5,8,6,8],[7,0,8,0],[7,1,8,1],[7,2,8,2],[7,8,8,8],[13,0,13,8],[32,0,34,0],[32,1,34,1],[32,2,34,2],[32,8,34,8],[36,0,37,0],[36,1,37,1],[36,2,37,2],[36,8,37,8],[41,0,41,8],[44,0,45,0],[44,1,45,1],[44,2,45,2],[44,8,45,8],[46,0,50,0],[46,1,50,1],[46,2,50,2],[46,3,50,3],[46,7,50,7],[46,8,50,8],[51,8,52,8],[54,0,56,0],[54,1,56,1],[54,2,56,2],[54,8,56,8],[57,0,61,0],[57,1,61,1],[57,2,61,2],[57,4,61,4],[57,8,61,8],[64,0,68,0],[64,1,68,1],[64,2,68,2],[64,8,68,8],[69,0,70,0],[69,1,70,1],[69,2,70,2],[69,8,70,8],[76,0,79,0],[76,1,79,1],[76,2,79,2],[76,3,79,3],[76,4,79,4],[76,8,79,8],[80,0,81,0],[80,1,81,1],[80,2,81,2],[80,8,81,8],[83,0,85,0],[83,1,85,1],[83,2,85,2],[83,8,85,8],[89,0,92,0],[89,1,92,1],[89,2,92,2],[89,8,92,8]],"flags":["formulas_cached_only"]}
["亞   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口\n(負責科技組)"]
["1","澳大利亞","蒙納許大學 Monash University","Faculty of Information Technology","1. 資訊處理科技及智慧運算 Information Technology and Intelligent Computing\n2. 材料科技 Materials Science & Technology","http://www.infotech.monash.edu.au/","David Green, Associate Dean&Research","Tel: +61 3 990 53912 \nFax: +61 3 990 55159\nEmail: David.Green@monash.edu","施孟君博士 02 2737 7150  (AU)"]
["2","澳大利亞","昆士蘭大學 The University of Queensland","Australian Institute for Bioengineering and Nanotechnology(AIBN)","1.生醫科學與工程Biomedical Science and Engineering\n2.材料科技 Materials Technology","http://www.aibn.uq.edu.au/about-aibn","Janice Besch, Deputy Director (Operations) ","Email: j.besch@uq.edu.au\nTelephone: +61 7 33463800 Facsimile: +61 7 33463973  ","施孟君博士 02 2737 7150  (AU)"]
["3","韓國","高麗大學Korea University","民族文化研究院","理論東亞","http://www.korea.edu/","(獲崔溶徹院長同意)","Tel: +02-3290-1610\nEmail: choe0419@korea.ac.kr","鄭慧娟研究員 02 2737 7472  (JP)"]
["4","日本","東京大學 The University of Tokyo","1. 地震研究所\n","1. 地震研究","1. http://www.eri.u-tokyo.ac.jp/eng/ \n","1. 平田直 (東京大学地震研究所所長)\n","1. Tel: 03-5841-5677  Fax: 03-5689-4467 E-mail:k-kenkyu@eri.u-tokyo.ac.jp ","鄭慧娟研究員 02 2737 7472  (JP)"]
[{"$nulls":3},"2. 比較文學比較文化研究室","2. 東亞研究","2. http://fusehime.c.u-tokyo.ac.jp/dept/index.html","2. 齋藤希史教授（Mareshi SAITO）教授","2. Tel: +81-29-860-4769 Email: FUKATA.Naoki@nims.go.jp"]
["5","日本","京都大學 Kyoto University","1. Center for Frontier Medicine of Department of Pharmacology","1. 炎症及免疫疾病相關之藥物研發","1. http://www.med.kyoto-u.ac.jp/GCOE/J/member/individual/narumiya.html\n","1. 成宮周 (Shuh Narumiya)教授","1. TEL:+81-75-753-4392   e-mail: snaru@mfour.med.kyoto-u.ac.jp","鄭慧娟研究員 02 2737 7472  (JP)"]
[{"$nulls":3},"(new) 2.アジア研究教育ユニット（Asian Studies Unit）‧应用哲學倫理学教育研究センタ","2.分析的亞洲哲學\nAnalytic Asian Philosophy","2.http://www.kuasu.cpier.kyoto-u.ac.jp/","2.出口康夫 教授 Yasuo DEGUCHI","2.email: yasuodeguchi@aol.com"]
["6","日本","東北大學 Tohoku University","Laboratory for Nanoelectronics and Spintronics Research Institute of Electrical Communication","自旋電子學Spintronics","http://www.ohno.riec.tohoku.ac.jp ","Prof. Hideo Ohno(大野 英男) Laboratory for Nanoelectronics and Spintronics, Research Institute of Electrical Communication, Tohoku University","Tel: +81-22-217-5553; Fax: +81-22-217-5555 or 5553 (direct) E-mail: ohno@riec.tohoku.ac.jp","鄭慧娟研究員 02 2737 7472  (JP)"]
["7","日本","獨立行政法人物質・材料研究機構National Institute for Materials Science (NIMS), Japan.",null,"1. 太陽能電池領域.                       (new) 2. Porous Materials.                       (new) 3. Bioceramics.                                 (new) 4. Organic Optoelectronic Materials. (new) 5. Biomaterials","http://www.nims.go.jp/eng/index.html","1. FUKATA Naoki.                       2. Yusuke Yamauchi.                      3. Yoshio Sakka.                             4. Masayoshi Higuchi.                   5. Guoping Chen.","1. FUKATA.Naoki@nims.go.jp\n2. YAMAUCHI.Yusuke@nims.go. jp  \n3. SAKKA.Yoshio@nims.go.jp  \n4. HIGUCHI.Masayoshi@nims.go.jp  \n5. Guoping.CHEN@nims.go.jp","鄭慧娟研究員 02 2737 7472  (JP)"]
[]
[]
["歐   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
["8","奧地利","維也納大學Universität Wien","Institute for Ethics and Law in Medicine; Institute for Systematic Theology and religious Studies","科技發展的倫理與法律意涵","http://etfst.univie.ac.at/home/; www.ierm.at","Ulrich Körtner 教授","T +43(1) 4277-22201 F +43 (1) 4277-9222 ulrich.koertner@univie.ac.at","鄭旭峰秘書 02 2737 7515    (DE)"]
["9","比利時","跨校際微電子研究中心 Interuniversity MicroElectronics Center (IMEC)","(IMEC)","1.Bio-micro-electromechanical System or Bio-electronics, 2.Nanoelectronics, 3.Design & Production Technology for System-on-Chip, 4.Smart Systems, 5. Wireless Autonomous Transducers, 6. Bio-electronics, 7. Heterogeneous Integration, etc.","www2.imec.be/be_en/home.html","Prof. Jo De Boeck Senoir Vice President Smart System and Energy Technology Jo.DeBoeck@imec-nl-nl","Tel:  +32 16 28 12 11 Fax: +32 16 22 94 00","陳禹銘博士 02 2737 7959   (BE)"]
["10","丹麥","Aarhus University","Religion, Cognition and Culture Research Unit (RCC), Dept. of Culture and Society","Religion and Cognition","http://www.au.dk/","Prof. Armin W. Geertz","Tel: 871-62473\nEmail: awg@teo.au.uk","傅顯達研究員   02 27377810  (BE)"]
["11","法國","國家衛生及醫學研究院 \nINSERM","Unité de Neuroimagerie Congnitive\nCEA/SAC//DRM/Neurospin Center","認知科學跨領域研究--心智、大腦與教育 Cognitive Science, Mind, Brain, and Education","INSERM-CEA Cognitive Neuroimaging Research Unit -INSERM 562是Neurospin研究中心四個研究組之一，神經顯像Neuroimaging研習領域為該中心專長","Dr. Denis Lebihan\nDirector","Tel: +33 01 69 08 82 05 Fax: +33 01 69 08 79 80 E-mail:denislb@aol.com","陶正統副研究員 02 2737 7431   (FR)"]
["12","法國","法國國家科學研究中心 (CNRS)","分子及細胞生物與基因研究所\n Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGMBC)\nCNRS 7104/INSERM67404/\nUniversity of Strasbourg","細胞生物與發育\n癌症生物學\n神經生物與基因\n功能基因組學\n結構生物","法國國家科學研究中心所屬 分子及細胞生物與基因研究所1994成立，研究所2001年成為CNRS/Inserm及史特拉斯堡大學聯合實驗室。IGBMC是歐洲最早成立專事研究生物醫學的研究單位。主要研究高等真核生物基因組及基因表達的控制與分析的功能基因與蛋白質。這些知識應用於人類疾病如癌症、單基因疾病、代謝性疾病等。該中心具有最新穎的老鼠醫院實驗室，以基因方法從老鼠身上作出病變研究。"," Dr. Brigitte KIEFFER/Director\n\n ","Tel: +33 03 88 65 32 16 E-mail: directeur.igbmc@igbmc.fr","陶正統副研究員 02 2737 7431   (FR)"]
["13","法國","巴斯德研究院 \nInstitut Pasteur","(Institut Pasteur)","Infectious diseases","世界知名研究機構","Mr Marc Jouan\nDirector of International Network","Tel: +33 01 45 68 81 48 \nFax: +33 01 45 68 89 52","陶正統副研究員 02 2737 7431   (FR)"]
["14","法國","歐洲同步輻射中心 European Synchrotron Radiation Facility (ESRF)","(ESRF)","光速線\n奈米科技\n生物科技","http://www.esrf.eu/","Prof. Francesco SETTE, Director General","E-mail: sette@esrf.fr","陶正統副研究員 02 2737 7431   (FR)"]
["15","德國","達姆施塔特高等資訊安全研究中心 (CASED)","( CASED)","1.理論及計算科學 Theoretical Science and  Computational Science, 2. 電子電信科技 Eelectronics and Telecommunication  Technology, 3.資訊安全","http://www.cased.de/en.html","Dr.-Ing. Michael Kreutzer Managing Director CASED Center for Advanced Security Research ","Tel: +49 (0) 6151 16-6165 Fax: +49 (0) 61 51 16-4825 E-Mail:kreutzer@cased.de URL:www.cased.de","鄭旭峰秘書 02 2737 7515    (DE)"]
["16","德國","德國Helmholtz 國家研究院","德國癌症研究中心 (DKFZ)","1. 生醫科學與工程Biomedical Science and Engineering, 2. 分子及細胞生物 Molecular and Cellular Biology, 3. 癌症醫學Oncology ","www.dkfz.de","Jana Grünewald, PhD\nCoordinator, International Affairs\n\n","Tel: +49 062 21. 42-2651  Email: j.gruenewald@dkfz-heidelberg.de","鄭旭峰秘書 02 2737 7515    (DE)"]
["17","德國","德國Helmholtz國家研究院","Juelich研究中心","1. 材料科學 Materials Science, 2. 能源科技 Energy Technology, 3. section Ethics in the Neurosciences","http://www.fz-juelich.de/portal/index.php?index=1096","Guenter Lincks, Head of International Relations","Tel: +49 02461 61-6232   Email: g.lincks@fz-juelich.de","鄭旭峰秘書 02 2737 7515    (DE)"]
["18","德國","德國Helmholtz國家研究院"," 德國分子醫學中心 Max Delbrück Center for Molecular Medicine (MDC)",null,"http://mdc-berlin.de/en/","Prof. Walter Rosenthal","(Ms) Dr. Oksana Seumenicht  Tel: +49 30 9406 3734  oksana.seumenicht@mdc-berlin.de","鄭旭峰秘書 02 2737 7515    (DE)"]
["19","德國","弗萊堡大學醫學中心\nUniversity Medical Center Freiburg","Medical Physics\nDepartment of Radiology","核磁共振","http://www.uniklinik-freiburg.de/mr/live/mitarbeiter/aktuelle/hennig_en.html","Prof. Jürgen Hennig","phone: +49 761 270 38360\nfax: +49 761 270 38310\nemail: juergen.hennig@uniklinik-freiburg.de","鄭旭峰秘書 02 2737 7515    (DE)"]
["20","荷蘭","鹿特丹伊拉斯姆斯大學\nErasmus University Rotterdam","Erasmus Happiness Economics Research Organization ","生活品質與福祉","http://www.narcis.nl/organisation/RecordID/ORG1243849/Language/en","Ruut Veenhoven","Tel: +31 10 4082102\nE-mail: veenhoven@ese.eur.nl ","傅顯達研究員   (BE)\n02 27377810"]
["21","俄羅斯","庫恰托夫研究院  Kurchatov Insitute","1. Nuclear Lab.\n2. Synchrotone","1. liquid salt fluorides\n2. X-ray ","http://www.kiae.ru/index4.html","Dr. Evgeniy Ugrinovich \n(Deputy Director, International S&T Cooperation)\nDr. Sergey Virgiliev ","Tel: +7-499-196-7696\nE-mail: polis@kiae.ru","鄭旭峰秘書 02 2737 7515   (RU)"]
["22","瑞士","洛桑聯邦理工學院  Ecole Polytechnique Fédérale de Lausanne (EPFL)","Photovoltaic Laboratory (PV Lab), Institute of Micro Technique (IMT)","太陽能電池領域","http://www.epfl.ch/index.en.html","Pofessor Michel Graetzel","Michael Graetzel' <michael.graetzel@epfl.ch>","鄭旭峰秘書 02 2737 7515   (DE)"]
["23","瑞士","蘇黎世聯邦理工學院\nEidgenössische Technische Hochschule Zürich",null,"engineering \nnatural sciences","www.global.ethz.ch","Maio Su Chen, Ph.D. (contact)","Tel: +41 44 632 8101\nFax: +41 44 632 1508\nEmail: maio.chen-su@sl.ethz.ch","鄭旭峰秘書 02 2737 7515    (DE)"]
["24","英國","倫敦帝國學院 Imperial College London","生醫工程研究所 (Institute of Biomedical Engineering)","生醫工程 Biomedical Engineering","http://www3.imperial.ac.uk/biomedeng","Professor Christofer Toumazou (contact)","E-mail: c.toumazou@imperial.ac.uk  Tel: +44 (0)207 594 6255","陶正統副研究員 02 2737 7431   (UK)"]
["25","英國","劍橋大學 University of Cambridge","1.Department of Experimental Psychology, 2. Institute of Behavioral and Clinical Neuroscience","認知科學跨領域研究--心智、大腦與教育Cognitive Science, Mind, Brain, and Education","1./2. http://www.psychol.cam.ac.uk/","1./2. Professor Trevor W. Robbins, FRS","1./ 2. E-mail: t.robbins@psychol.cam.ac.uk","陶正統副研究員 02 2737 7431   (UK)"]
[{"$nulls":3},"3. Centre for Neuroscience in Education ",null,"3. http://www.educ.cam.ac.uk/centres/neuroscience/","3. Professor Usha Goswami  ","3. E-mail: ucg10@cam.ac.uk Tel: +44 (0)122 376 7635"]
[{"$nulls":3},"4. Department of Psychiatry ",null,"4.\nhttp://www.psychiatry.cam.ac.uk/","4. Prof. Edward Bullmore (contact)","4. E-mail: etb23@cam.ac.uk  Tel: +44(0)1223 336583"]
["26","英國","倫敦大學學院 University College London","婦女研究所 (Institute for Women's Health)","1.生醫工程 Biomedical sciences and engineering, 2.分子及細胞生物學 Molecular and cellular biology","www.instituteforwomenshealth.ucl.ac.uk ; \nhttp://www.ucl.ac.uk/ich/homepage","a. Dr. Peter Brocklehurst, Director of Institute for Women's Health \nb. Dr. Rosalind Smyth, Director of Institute of Child Health","a. E-mail: p.brocklehurst@ucl.ac.uk Tel: +44 20 7679 6060 ; \nb. E-mail: rosalind.smyth@.ucl.ac.uk Tel: +44 20 7905 235","陶正統副研究員 02 2737 7431   (UK)"]
["27","英國","愛丁堡大學\nUniversity of Edinburgh","1.能源系統研究所Institute for Energy Systems","1. 海洋能源 Marine Energy","1. http://www.see.ed.ac.uk/research/IES/","1. Prof. A Robin Wallace","1. Robin.Wallace@ed.ac.uk Tel: +44 (0)131 650 5587 ","陶正統副研究員 02 2737 7431   (UK)"]
[{"$nulls":3},"2. 極端條件科學研究中心Center for Science at Extreme Condition","2.材料科技 Materials Science","2. http://www.csec.ed.ac.uk/","2. Professor J. Paul Attfield","2. j.p.attfield@ed.ac.uk Tel: +44 (0)131 631 7229"]
["28","英國","南安普敦大學\nUniversity of Southampton","Optoelectronics Research Centre","Nanophotonics and Metamaterials\nMaterials Science & Technology\nEnergy Technology & Electronics\nTelecommunications Technologies","www.southampton.ac.uk/orc","Prof. N.I. Zheludev","email: zheludev@soton.ac.uk\ntel: +44 23 8059 3566","陶正統副研究員 02 2737 7431   (UK)"]
[]
[]
["美   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
["29","加拿大","加拿大同步光源中心  Canadian Light Source ",null,"Synchrotron Radiation-related Sciences","http://www.lightsource.ca/","Prof. T. K. Sham","E-mail: tsham@uwo.ca","胡秀娟研究員 02 2737 7560   (CA)"]
["30","加拿大","英屬哥倫比亞大學  The University of British Columbia   ","1. Michael Smith Laboratories","1. 生物科技Biotechnology","1. http://www.msl.ubc.ca/ ","1. Dr. Jim Kronstad, Director, MSL","1. Tel: +1 604 822-4732 E-mail: kronstad@msl.ubc.ca","胡秀娟研究員 02 2737 7560   (CA)"]
[{"$nulls":3},"2. Clean Energy Research Centre (CERC)","2. 能源科技Energy Technology","2. http://www.cerc.ubc.ca/","2. Dr. David Wilkinson, Director, CERC","2. Tel: +1 604 827-4342 E-mail: dwilkinson@chbe.ubc.ca"]
[31,"加拿大","渥太華大學University of Ottawa ","光子學研究中心 Centre for Research in Photonics","1. 飛秒科學實驗室Attosecond Science Lab                                                                                                                                              ","1.http://www.jaslab.ca\n                                                         ","1. Prof. Paul Corkum, Canada Research Chair Tier 1 in Attosecond Photonics                                                                ","Pierre Berini,                                Director, Centre for Research in Photonics /                                    Chair in Surface Plasmon Photonics,                                    Tel: (613) 562-5800 ext. 6316, http://www.eecs.uottawa.ca/~berini/","胡秀娟研究員 Jennifer Hu  02 2737 7561   (CA)"]
[{"$nulls":4},"2. 量子光子學Quantum photonics      ","2.http://www.quantumphotonics.uottawa.ca/","2. Prof. Robert Boyd, Canada Excellence Research Chair in Quantum Nonlinear Optics               "]
[{"$nulls":4},"3. 表面電漿光子學Surface Plasmon Photonics   ","3.http://www.site.uottawa.ca/~berini/research.html         ","3. Prof. Pierre Berini, Chair in Surface Plasmon Photonics    "]
[{"$nulls":4},"4. 分子光子學Molecular Photonics","4.http://www.chem.queensu.ca/people/faculty/Stolow/Home.html","4. Prof. Albert Stolow, Adjunct Professor and NRC Program leader of the Molecular Photonics Group"]
[{"$nulls":4},"5. 高速光子學Ultra-fast Photonics","5.http://mysite.science.uottawa.ca/brabec/index.html","5. Prof. Thomas Brabec, Canada Research Chair Tier 1 in Ultra-fast Photonics"]
["32-1","加拿大","多倫多大學  University of Toronto","Terrence Donnelly Centre for Cellular and Biomolecular Research Center","生醫科學與工程Biomedical Science and Engineering","http://tdccbr.med.utoronto.ca/research/platforms.html     http://tdccbr.med.utoronto.ca/faculty/directors_welcome.html  ","Dr. Brenda J. Andrews, Director","Tel: 416-978-8562         Fax: 416-978-8287             E-mail: brenda.andrews@utoronto.ca ","胡秀娟研究員 02 2737 7560   (CA)"]
["32-2","加拿大","University Health Network, Toronto","Advanced Medical Discovery Institute & The Campbell Family for Breast Cancer Research Institute, Princess Margaret Hospital","癌細胞代謝重新編程研究（Metabolic reprogramming research in cancer cells）","http://www.theprincessmargaret.ca/en/FindaPerson/Pages/ScientistProfile.aspx?personid=254","Prof. Tak Wah Mak, Director","Tel: 416 946-4501  E-mail: tmak@uhnres.utoronto.ca"]
["33","美國","阿岡國家實驗室  Argonne National Laboratory",null,"1.Materials and Molecular Design and Discovery \n2.Hard X-Ray Sciences \n3. Structural Biology","http://www.anl.gov/","Mr. Norman D. Peterson, Assistant to the Director","Tel: +1 630 252 7229\nFax: +1 630 252 7923\nnpeterson@anl.gov","胡秀娟研究員 02 2737 7560  (DC)"]
["34","美國","美國國家衛生研究院  National Institutes of Health (NIH)","The Intramural Research Program (IRP), National Institute on Drug abuse (NIDA)","Optogenetics in the Understanding of Brain Functions","http://www.irp.drugabuse.gov","(1a) Dr. Antonello Bonci, Professor and Institute Scientific Director; and (1b) Dr. Brandon Harvey, Director, Optogenetics and Transgenetics Core Facility.","Dr. Bonci: Tel: 443-740-2463; Dr. Harvey: 443-740-2590","胡秀娟研究員 02 2737 7560  (DC)"]
[{"$nulls":3},"(new) 2.National Institute of Neurological Disorders and Stroke (NINDS)","(NIH-NINDS)"]
[{"$nulls":3},"(new) 3. National Cancer Institute (NCI) ","(NIH-NCI)"]
["35","美國","哥倫比亞大學 Columbia University","1. Lamont-Doherty Earth Observatory","1. Earth Sciences,\n2. Energy Frontier Research Center,\n3. Integrated Circuit Design for Nanoscale Technologies,\n4. Multimedia Computing and Information,\n5. Nanoscience and Nanotechnology  ","1. http://www.ldeo.columbia.edu/","1a. Dr. Colin Stark; 1b. Prof Adam Sobel; 1c. Dr. Suzana Camargo; 4. Prof.  Goran Ekstrom","(如分頁)","胡秀娟研究員 02 2737 7560  (DC)"]
[{"$nulls":3},"2. Columbia Energy Frontier Research Center",null,"2. www.cise.columbia.edu/efrc","2. Dr. Tony Heinz; 2b. Dr. Louis Brus; 2c. Dr. James Yardley","(如分頁)"]
[{"$nulls":3},"3. Columbia Integrated Systems Laboratory",null,"3. http://www.ee.columbia.edu/~kinget","3. Prof. Peter Kinget","3. kinget@ee.columbia.edu"]
[{"$nulls":3},"4. DVMM Lab",null,"4. http://www.ee.columbia.edu/ln/dvmm/","4. 主任張世富教授\nDr.Shih-Fu Chang","4. Tel: +1 212-854-6894 Fax:+1 212-932-9421 E-mail: sfchang@ee.columbia.edu"]
[{"$nulls":3},"5. Columbia Nanoscale Science and Engineering Center",null,"5. www.cise.columbia.edu/nsec","5. Dr. Tony Heinz; 5b. Dr. Ronald Breslow; 5c. Dr. James Yardley","(如分頁)"]
["36","美國","哈佛大學  Harvard University","東亞語言與文明系","東亞文化","http://harvardealc.org/home.php","王德威教授(David Der-wei Wang)","dwang@fas.harvard.edu \n(617) 496-0925 ","胡秀娟研究員 02 2737 7560  (DC)"]
["37","美國","約翰霍普金斯大學  Johns Hopkins University","The Materials Research Science and Engineering Center (MRSEC) at the Johns Hopkins University (JHU)","Magnetoelectronic effects and devices","http://mrsec.jhu.edu/","Prof. Chia-Ling Chien 錢嘉陵教授\n","Tel: 410-516-8092 Fax: 410-516-7239","胡秀娟研究員 02 2737 7560  (DC)"]
["38","美國","麻省理工學院  MIT","1.Computer Science and Artificial Intelligence Laboratory","1. Chinese Language Learning Software and Multimedia","1. http: //www.sls.csail.mit.edu, 5. http://web.mit.edu/nse/people/faculty/chen.html","1. Prof. Victor Zue","1. E-mail: zue@csail.mit.edu","胡秀娟研究員 02 2737 7560  (DC)"]
[{"$nulls":3},"2.the David H. Koch Institute for Integrative Cancer Research","2. Cancer Research","2. http://ki.mit.edu/","2. Robert G. Urban, Ph.D (contact)","2. Tel: +1 617-324-3533 E-mail: rurban@mit.edu"]
[{"$nulls":3},"3.Picower Institute for Learning and Memory","3. Brain and Cognitive Sciences","3. http://bcs.mit.edu/people/tsai.html, http://web.mit.edu/picower/faculty/tsai.html","3. 蔡立慧院士Prof. Li-Huei Tsai"]
[{"$nulls":3}," 4.Dept. of Nuclear Science and Engineering"," 4. Nuclear Science and Engineering","4. http://web.mit.edu/nse/people/faculty/chen.html","4.陳守信教授 Prof. Sow-Hsin Chen","4. Email: sowhsin@mit.eduPhone: +1 (617) 253-3810 Fax: +1 (617) 258-8863"]
[{"$nulls":3},"5.Department: Foreign Languages and Literature","5.Intercultural Exchange in Greater China","5. http://web.mit.edu/fll/www/people/EmmaTeng.shtml","5. Emma Teng Chung","5. Email: eteng@mit.edu"]
["39","美國","貝勒醫學院   Baylor College of Medicine","1. Department of Pathology & Immunology & Department of Molecular & Cellular Biology, ","1. RNA molecular switches and RNA mutations in cancer","1. http://www.bcm.edu/pathimmuno/yen/index.cfm?PMID=14409","1. Assistant Professor Laising Yen (嚴來興)  http://www.bcm.edu/pathimmuno/yen/?pmid=21095","1. Tel: +1 713-798-1180; e-mail: yen@bcm.edu","胡秀娟研究員 02 2737 7560   (HU)"]
[{"$nulls":3},"(new) 2. Departments of Molecular and Cellular Biology and Medicine and Program of Development ","2. Molecular Endocrinology and Development Biology\n","\n2.https://www.bcm.edu/education/programs/developmental-biology/db_fac-tsaim.html  "," 2.C.C. Bell Distinguished Service Professor Ming-Jer Tsai (蔡明哲院士)\nhttps://www.bcm.edu/departments/molecular-and-cellular-biology/?pmid=7576","\n2.Tel: +1 713-798-6253; e-mail: mtsai@bcm.edu"]
["40","美國","美國國家大氣研究中心  National Center for Atmospheric Research (NCAR)","Mesoscale &Microscale Meteorology, Climate and global dynamics, etc.","大氣科學研究、\n氣候變遷及氣象相關研究","http://www.ncar.ucar.edu","Ying-Hwa Kuo \nHead Mesoscale prediction group","email: kuo@nvar.ucar.edu,      \nTel: 303-497-8910","胡秀娟研究員 02 2737 7560  (HU)"]
["41","美國","萊斯大學  Rice University","Department of Religious Studies","psychology of religion ","http://www.rice.edu/","William B. Parsons教授","pars@rice.edu","胡秀娟研究員 02 2737 7560  (HU)"]
["42","美國","德州大學-奧斯汀分校   The University of Texas Austin","Department of Electrical and Computer Engineering","1. Bio-sensor for cancer detection and Environmental sensors 2. Energy harvest through energy collection, or 3.Electronics and Telecommunication Technology","http://muri.engr.utexas.edu/ ; http://www.mrc.utexas.edu/index.php/peoplemain/106","Prof. Ray Chen (陳瑞曾), Cullen Trust Endowed Professor & Director of MURI center for Silicon Nanomembranes","Tel: +1 512 471-7035\nFax: +1 512 471-8575\nEmail: chen@ece.utexas.edu  ","胡秀娟研究員 02 2737 7560  (HU)"]
["43","美國","德州大學--安德森癌症中心  The University of Texas MD Anderson Cancer Center at the Texas Medical Center","Dept. of  Molecular and Cellular Oncology, Dept. of Cardiology, etc.","癌症醫療與研究\n健康照護\n醫院管理","http://www.mdanderson.org/ http:// www.texasmedicalcenter.org","洪明奇院士  \nMien-Chie Hung  ","email: mhung@mdanderson.org,TEL: 713-792-3668","胡秀娟研究員 02 2737 7560  (HU)"]
[44,"美國","德州大學-西南醫學中心   The University of Texas Southwestern Medical Center","Department of Urology","生醫科學與工程Biomedical Science and Engineering","http://www.utsouthwestern.edu/fis/faculty/13361/jer-tsong-hsieh.html","Jer-Tsong Hsieh（謝哲宗）","Tel: +1 214 648-3988 JT.Hsieh@UTSouthwestern.edu","胡秀娟研究員 02 2737 7560  (HU)"]
["45","美國","加州理工學院  California Institute of Technology",null,"1. Astronomy/Astrophysics/Space Studies, 2. \"Beyond Si-CMOS\" nano-electronic research, 3. Biophysics & Nano-biootechnology, 4. Energy Research\n(須以計畫構想書與對方洽定後始可提出)","1. http://www.astro.caltech.edu","1.Prof. B.Thomas Soifer","1. bts@irastro.caltech.edu","胡秀娟研究員 02 2737 7560  (LA)"]
[{"$nulls":5},"2. http://www/its.caltech.edu/~yehgroup/, http://kni.caltech.edu","2. Prof. Nai-Cjamg Yeh"," 2. ncyeh@caltech.edu"]
[{"$nulls":5},"3. http://mems.caltech.edu, http://www/its/caltech.edu/~nano/, http://kni.caltech.edu","3. Prof. Yu-Chong Tai","3. tai@mems.caltech.edu, roukes@caltech.edu"]
[{"$nulls":5},"4. http://resnick.caltech.edu, http://www/lmi.caltech.edu/, http://solarfuelshub.org, http://daedalus.caltech.edu","4. Prof. Harry Atwater","4. haa@caltech.edu"]
["46","美國","南加州大學  University of Southern California","1. USC-Taiwan center for Translational Research","1. Development of novel therapeutics for targeted drug development","1. http://pharmacyresearch.usc.edu/centers/translational-research  ","1. Jean Chen Shih Ph.D.(陳景虹院士),   Bogdan Olenuk Ph.D., Kevin Chen Ph.D., Clay CC Wang Ph.D., Mitchell E Gross M.D. Ph.D., Leland Cheung Ph.D., Florence Hofman Ph.D., Thomas Chen M.D. Ph.D.","1. Tel:323 442 1441  Fax:323 224 7473\ne-mail: jcshih@usc.edu\n","胡秀娟研究員 02 2737 7560   (LA)"]
[{"$nulls":3},"2. Laboratory of Tissue Development and Regeneration","2. 生醫科學與工程Biomedical Science and Engineering","2 http://www-hsc.usc.edu/~cmchuong/researchinterests.html","2. 鍾正明(Cheng-Ming Chuong )","2. cmchuong@nsc.edu"]
["47-1","美國","加州大學-洛杉磯分校  University of California-Los Angeles(UCLA)","3. Optoelectronic Biofluidics Laboratory; 4. Electrical Engineering Department ","1. Nanoelectronics and nano-spintronics beyond CMOS;  2. 材料科技;  3. biophotonics, nanophotonics, and lab-on-a-chip systems; 4. Nonlinear Optics, Ultrafast Optics, Semiconductor Lasers, Photonic Devices, Nonlinear Laser Dynamics, Chaotic Communications, Optical Imaging, High speed electronics    ","3. http://oeb.seas.ucla.edu/OEB.html \n4. http://www.ee.ucla.edu/people/faculty/faculty-directory/jia-ming-liu ","1. Prof.Kang L Wang; 2. Prof. King-Ning Tu; Prof. Yang Yang; Prof. J.-M. Yang, etc.;  3. Prof. Eric Pei-Yu Chiou (邱培鈺); 4. Prof. Jia-Ming Liu   (劉佳明); Prof. Frank M C  Chang (張懋中)","1. Tel: 310-825-1609 Fax: 310-206-7154 E-mail: wang@ee.ucla.edu (NanoSystems Institute);  2. www.fena.org; www.win-nano.org; www.drl.ee.ucla.edu; 3.Tel +1 310-825-8620 pychiou@seas.ucla.edu; 4. (劉佳明) Tel +1 310 206-2097 liu@ee.ucla.edu; (張懋中) Tel+1 310 794 1633  mfchang@ee.ucla.edu","胡秀娟研究員 02 2737 7560   (LA)"]
["47-2","美國","加州大學-聖地牙哥分校  University of California-San Diego\n(含The Scripps Research Institute)","1. School of Engineering","Bioengineering;\nElectrical and Computer Engineering;\nMechanical and Aerospace Engineering","http://be.ucsd.edu/; http://www.cse.ucsd.edu/; http://maeweb.ucsd.edu/","1a. Prof. Lanping Amy Sung; 1b. Prof. Robert Sah; 1c. Prof. Gert Cauwenberghs; 1d. Prof. Yuhwa Lo; 1e. Prof. Juan Lasheras","1a. Tel:  +1 858-534-0821 E-mail: lasung@ucsd.edu ;  1b. Tel:  +1 858-534-0821 E-mail: rsah@ucsd.edu 1c. Tel: +1 858-534-6938 E-mail:  gert@ucsd.edu; 1d. Tel: +1 858-822-3429 E-mail: ylo@ucsd.edu; 1e. Tel: +1 858-534-5437 Fax: 858-534-7599","胡秀娟研究員 02 2737 7560   (LA)"]
[{"$nulls":3},"2. Swartz Center for Computational Neuroscience, etc.","http://sccn.ucsd.edu/~jung/Site/Home.html","2. http://sccn.ucsd.edu/index.html; ","2. Prof. Tzyy-Ping Jung(鍾子平)","Tel: +1 858 366-8914 E-mail: tpjung@ucsd.edu"]
[{"$nulls":3},"(new) 3.Department of Medicine/Division of Cardiology",null,"3. http://medschool.ucr.edu/faculty_research/faculty_profiles/bio.html?page=shyy_john.html","3. John Y-J. Shyy, Ph.D.(史允中)","Tel: +1  858 534-3736\nFax: 858-822-3027\nE-mail: jshyy@ucsd.edu"]
["47-3","美國","加州大學-柏克萊分校  University of California-Berkeley"," the Center for Energy Efficient Electronics Science (E3S)","Nanoelectronics, Nanomechanics, Nanophotonics, and Nanomagnetics","http://www.e3s-center.org/ ","1. M. Josephine Yuen, Ph.D., Executive Director of Center for Energy Efficient Electronics Science\n2. Prof. Ming C. Wu (吳明強教授), http://www.eecs.berkeley.edu/Faculty/Homepages/wu.html",null,"胡秀娟研究員 02 2737 7560   (SF)"]
["47-4","美國","加州大學-舊金山分校   University of California-\nSan Francisco","Department of \nBioengineering and \nTherapeutic Sciences","pharmacogenomics of\n membrane transporters and \nin pharmacogenomics of  metformin. ","http://bts.ucsf.edu \nhttp://bts.ucsf.edu/people/faculty/profiles/?counter=12","Kathleen M. Giacomini, Ph.D.\nProfessor & Co-Chair","Tel: +1 415 476-1936\nE-mail: kathy.giacomini@ucsf.edu","胡秀娟研究員 02 2737 7560  (SF)"]
["48","美國","勞倫斯伯克利國家實驗室   Lawrence Berkeley National Laboratory","Advanced Light Source","Synchrotron Radiation-related Sciences","http://www.lbl.gov/"," Dr. Haimei Zheng",null,"胡秀娟研究員 02 2737 7560   (SF)"]
["49","美國","史丹佛大學  Stanford University","1. Structures and Composites Laboratory","1. a. Structural Health Monitoring; b. Design of Integrated Strctures; c. Smart Structures; d. Design & Damage Tolerance of Composites Structures; e. Multi-Functinal Materials","1. http://structure.stanford.edu/","1. 張福國教授  Fu-Kuo Chang","1. Tel: +1 650 723-3466 E-mail: fkchang@stanford.edu","胡秀娟研究員 02 2737 7560   (SF)"]
[{"$nulls":3},"2. SLAC National Accelerator Laboratory","2. a. Accelerator physics; b. Astrophysics and Cosmology; c. Elementary Parti","2. https://www6.slac.stanford.edu/","2. 趙午院士 Alexander Chao","2.Tel: +1 650 926-2985 E-mail: achao@slac.stanford.edu"]
[{"$nulls":3},"3.Computational Biology Laboratory","3. a. Computational Biology; b. Machine Learning; c. Big Data","3. www.stanford.edu/group/wonglab/ ","3.王永雄院士Wing Hung Wong","3. Tel: +1 650 725-2915  E-mail: whwong@stanford.edu"]
[{"$nulls":3},"(new) 4.Stanford Center on Poverty & Inequality","4. To develop an improved infrastructure for measuring and explaining trends in poverty, inequality, and other distributive outcomes.  \nResearch addressing such issues of measurement in the fields of \n(a) poverty, \n(b) income inequality, \n(c) social mobility, \n(d) educational access, \n(e) the safety net, \n(f) the recent recession, \n(g) racial inequality, \n(h) residential segregation and poverty, and \n(i) poverty and discrimination\n (for details go http://www.stanford.edu/group/scspi/research_home.html). ","4. http://www.stanford.edu/group/scspi/","4. David B. Grusky\nProfessor, Dept. of Sociology\nDirector, Stanford Center on Poverty & Inequality\n","4. Website: www.grusky.org\nEmail: grusky@stanford.edu\nTel: +1 650 724-6912\n"]
[]
[{"$nulls":3},"備註:","以藍色底色列出者屬2014年新增之機構。"]
[{"$nulls":4},"原列機構中，以紅字列出者且前加註(new)，表示係2014年新加入之實驗室。"]
[{"$nulls":4},"上述2類新加入的單位亦將資訊抽出並另列於\"2014年新加入者\"之工作頁內，俾利參考。"]

{"sheet":"2014年新加入者","index":2,"n_rows":23,"n_cols":9,"rows_kept":23,"merged":[[0,0,0,8],[6,0,6,8],[14,0,14,8],[17,4,17,7],[20,0,21,0],[20,1,21,1],[20,2,21,2]],"flags":["formulas_cached_only"]}
["亞   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
["1","日本","京都大學 Kyoto University","2.アジア研究教育ユニット（Asian Studies Unit）‧应用哲學倫理学教育研究センタ","2.分析的亞洲哲學\nAnalytic Asian Philosophy","2.http://www.kuasu.cpier.kyoto-u.ac.jp/","2.出口康夫 教授 Yasuo DEGUCHI","2.email: yasuodeguchi@aol.com","鄭慧娟副研究員 02 2737 7472"]
["2","日本","獨立行政法人物質・材料研究機構National Institute for Materials Science (NIMS), Japan.",null,"2. Porous Materials.                          3. Bioceramics.                                 4. Organic Optoelectronic Materials. 5. Biomaterials","http://www.nims.go.jp/eng/index.html","2. Yusuke Yamauchi.                      3. Yoshio Sakka.                             4. Masayoshi Higuchi.                   5. Guoping Chen.","2. YAMAUCHI.Yusuke@nims.go. Jp\n3. SAKKA.Yoshio@nims.go.jp\n4. HIGUCHI.Masayoshi@nims.go.jp\n5. Guoping.CHEN@nims.go.jp","鄭慧娟副研究員 02 2737 7472"]
["3","澳大利亞","蒙納許大學 Monash University","Faculty of Information Technology","1. 資訊處理科技及智慧運算 Information Technology and Intelligent Computing\n2. 材料科技 Materials Science & Technology","http://www.infotech.monash.edu.au/","David Green, Associate Dean&Research","Tel: +61 3 990 53912 \nFax: +61 3 990 55159\nEmail: David.Green@monash.edu","施孟君博士 02 2737 7150"]
[]
["歐   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
["4","德國","弗萊堡大學醫學中心\nUniversity Medical Center Freiburg","Medical Physics\nDepartment of Radiology","核磁共振","http://www.uniklinik-freiburg.de/mr/live/mitarbeiter/aktuelle/hennig_en.html","Prof. Jürgen Hennig","phone: +49 761 270 38360\nfax: +49 761 270 38310\nemail: juergen.hennig@uniklinik-freiburg.de","鄭旭峰秘書 02 2737 7515"]
["5","荷蘭","鹿特丹伊拉斯姆斯大學\nErasmus University Rotterdam","Erasmus Happiness Economics Research Organization ","生活品質與福祉","http://www.narcis.nl/organisation/RecordID/ORG1243849/Language/en","Ruut Veenhoven","Tel: +31 10 4082102\nE-mail: veenhoven@ese.eur.nl ","傅顯達研究員\n02 27377810"]
["6","瑞士","蘇黎世聯邦理工學院\nEidgenössische Technische Hochschule Zürich",null,"engineering \nnatural sciences","www.global.ethz.ch","Maio Su Chen, Ph.D.","Tel: +41 44 632 8101\nFax: +41 44 632 1508\nEmail: maio.chen-su@sl.ethz.ch","鄭旭峰秘書 02 2737 7515"]
["7","英國","南安普敦大學\nUniversity of Southampton","Optoelectronics Research Centre","Nanophotonics and Metamaterials\nMaterials Science & Technology\nEnergy Technology & Electronics\nTelecommunications Technologies","www.southampton.ac.uk/orc","Prof. N.I. Zheludev","email: zheludev@soton.ac.uk\ntel: +44 23 8059 3566","陶正統副研究員 02 2737 7431"]
[]
[]
["美   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
[8,"加拿大","渥太華大學University of Ottawa ","光子學研究中心 Centre for Research in Photonics","1. Attosecond Science Lab                                 2. Quantum photonics                                                3. Surface Plasmon Photonics                    4. Molecular Photonics                    \n5. Ultra-fast Photonics                                ","1.http://www.jaslab.ca\n2.http://www.quantumphotonics.uottawa.ca/\n3.http://www.site.uottawa.ca/~berini/research.html                                                                  \n4.http://www.chem.queensu.ca/people/faculty/Stolow/Home.html\n5.http://mysite.science.uottawa.ca/brabec/index.html","1. Prof. Paul Corkum, Canada Research Chair Tier 1 in Attosecond Photonics                          2. Prof. Robert Boyd, Canada Excellence Research Chair in Quantum Nonlinear Optics                                   3. Prof. Pierre Berini, Chair in Surface Plasmon Photonics               \n4. Prof. Albert Stolow, Adjunct Professor and NRC Program leader of the Molecular Photonics Group       5. Prof. Thomas Brabec, Canada Research Chair Tier 1 in Ultra-fast Photonics","Pierre Berini,                                Director, Centre for Research in Photonics /                                    Chair in Surface Plasmon Photonics,                                    Tel: (613) 562-5800 ext. 6316, http://www.eecs.uottawa.ca/~berini/","胡秀娟研究員 Jennifer Hu  02 2737 7561"]
[9,"美國","National Institutes of Health (NIH)","2.National Institute of Neurological Disorders and Stroke (NINDS)\n3. National Cancer Institute (NCI) ","NIH研習單位資訊",{"$nulls":3},"胡秀娟研究員 02 2737 7560"]
["10","美國","University of California-San Diego\n(含The Scripps Research Institute)","3.Department of Medicine/Division of Cardiology",null,"3. http://medschool.ucr.edu/faculty_research/faculty_profiles/bio.html?page=shyy_john.html","3. John Y-J. Shyy, Ph.D.(史允中)","Phone: 858-534-3736\nFax: 858-822-3027\nE-mail: jshyy@ucsd.edu","胡秀娟研究員 02 2737 7560"]
["11","美國","Stanford University","4.Stanford Center on Poverty & Inequality","4. To develop an improved infrastructure for measuring and explaining trends in poverty, inequality, and other distributive outcomes.  \nResearch addressing such issues of measurement in the fields of \n(a) poverty, \n(b) income inequality, \n(c) social mobility, \n(d) educational access, \n(e) the safety net, \n(f) the recent recession, \n(g) racial inequality, \n(h) residential segregation and poverty, and \n(i) poverty and discrimination\n (for details go http://www.stanford.edu/group/scspi/research_home.html). ","4. http://www.stanford.edu/group/scspi/","4. David B. Grusky\nProfessor, Dept. of Sociology\nDirector, Stanford Center on Poverty & Inequality\n","4. Website: www.grusky.org\nEmail: grusky@stanford.edu\nPhone: 1.650.724.6912\n","胡秀娟研究員 02 2737 7560"]
["12","美國","University of Southern California","1. USC-Taiwan center for Translational Research","1. Development of novel therapeutics for targeted drug development","1. http://pharmacyresearch.usc.edu/centers/translational-research  ","1. Jean Chen Shih Ph.D.(陳景虹院士),  Bogdan Olenuk Ph.D., Kevin Chen Ph.D., Clay CC Wang Ph.D., Mitchell E Gross M.D. Ph.D., Leland Cheung Ph.D., Florence Hofman Ph.D., Thomas Chen M.D. Ph.D.","1. Tel:323 442 1441  Fax:323 224 7473\ne-mail: jcshih@usc.edu\n","胡秀娟研究員 02 2737 7560"]
[{"$nulls":3},"2. Laboratory of Tissue Development and Regeneration","2. 生醫科學與工程Biomedical Science and Engineering","2 http://www-hsc.usc.edu/~cmchuong/researchinterests.html","2. 鍾正明(Cheng-Ming Chuong )","2. cmchuong@nsc.edu","胡秀娟研究員 02 2737 7560"]
["13","美國","貝勒醫學院\nBaylor College of Medicine","2 Departments of Molecular and Cellular Biology and Medicine and Program of Development ","2. Molecular Endocrinology and Development Biology\n","\n2.https://www.bcm.edu/education/programs/developmental-biology/db_fac-tsaim.html  ","2.C.C. Bell Distinguished Service Professor Ming-Jer Tsai (蔡明哲院士)\nhttps://www.bcm.edu/departments/molecular-and-cellular-biology/?pmid=7576","\n2.Tel: +1 713-798-6253; e-mail: mtsai@bcm.edu","胡秀娟研究員 02 2737 7560"]

{"sheet":"關鍵領域2014","index":3,"n_rows":18,"n_cols":3,"rows_kept":18,"merged":[[0,0,0,1],[1,0,1,1]],"flags":["formulas_cached_only"]}
["國科會  補助任務導向型團隊赴國外研習作業要點"]
["2014年度 關鍵性科技與人文社會領域"]
[" 序號","103年度領域別"]
[1,"地球科技 Earth Science & Technology"]
[2,"理論及先進量子相關科學 Theoretical and Advanced Quantum-related Science"]
[3,"同步輻射相關研究 Synchrotron Radiation-related Sciences"]
[4,"生醫科學與工程Biomedical Science and Engineering"]
[5,"分子及細胞生物 Molecular and Cellular Biology "]
[6,"生物多樣性與生態 Biodiversity and Ecology"]
[7,"材料科技 Materials Science & Technology"]
[8,"能源科技 Energy Technology [內含有機太陽能電池 Organic Phototvoltaics included]"]
[9,"電子電信科技 Electronics and Telecommunication  Technology"]
[10,"高齡社會與健康照護 Ageing Society and Health Care"]
[11,"認知科學跨領域研究--心智、大腦與教育 Cognitive Science, Mind, Brain, and Education"]
[12,"資訊處理科技及智慧運算 Information Technology and Intelligent Computing","新增"]
[13,"社會發展與福祉 (Social development and well-being): \n(1)生活品質與福祉(Quality of life and well-being) \n(2)社會資本 (Social capital) \n(3)社會階層與分配 (Social stratification and distribution) ","新增"]
[14,"亞洲研究( Asian Studies)\n(1)東亞研究 East Asia Studies \n(2)分析的亞洲哲學 Analytic Asian Philosophy ","調整"]
[15,"科技發展的倫理、法律與宗教意涵 Ethical, Legal, Religious & Social Issues"]

{"sheet":"NIH研習單位資訊","index":4,"n_rows":36,"n_cols":9,"rows_kept":36,"merged":[[0,0,0,8]],"flags":["formulas_cached_only"]}
["美   洲"]
["項次","國別","研習機構","研習單位","研習領域","研習單位介紹","國外研習機構\n指導或聯絡人姓名/職稱","聯絡資訊","國合處窗口"]
[null,"美國","National Institutes of Health (NIH)","The Intramural Research Program (IRP), National Institute on Drug abuse (NIDA)","Optogenetics in the Understanding of Brain Functions","http://www.irp.drugabuse.gov","(1a) Dr. Antonello Bonci, Professor and Institute Scientific Director; and (1b) Dr. Brandon Harvey, Director, Optogenetics and Transgenetics Core Facility.","Dr. Bonci: Tel: 443-740-2463; Dr. Harvey: 443-740-2590","胡秀娟研究員 02 2737 7560"]
[null,"美國","National Institutes of Health (NIH)"," (1)National Institute of Neurological Disorders and Stroke (NINDS)-項次1~5\n(2)National Cancer Institute (NCI)-項次6~32",{"$nulls":4},"胡秀娟研究員 02 2737 7560"]
["1","美國","National Institutes of Health (NIH)","Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS)","Biomedical Informatics Research in Neuroscience","http://intra.ninds.nih.gov","Dr. Yang C. Fann, Director, Intramural IT and Bioinformatics Program.","Dr. Fann: Tel: 301-451-5153; Email: fann@ninds.nih.gov","胡秀娟研究員 02 2737 7560"]
["2","美國","National Institutes of Health (NIH)","Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS)","Patient iPS Cell Engineering for Parkinson Disease Therapy","http://intra.ninds.nih.gov","Mahendra Rao, MD, PhD\nSenior Investigator\nDirector\nCenter for Regenerative Medicine\n","mahendra.rao@nih.gov","胡秀娟研究員 02 2737 7560"]
["3","美國","National Institutes of Health (NIH)","Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS)","Mechanisms of Mitochondria Transport and Quality Control in Healthy and Diseased Neurons","http://intra.ninds.nih.gov","Zu-Hang Sheng, PhD, Senior Principal Investigator, \nChief of Synaptic Functions Section\n","NINDS, NIH\nBuilding 35 (PNRC), Room 2B-215\n35 Convent Drive, MSC 3706\nBethesda, Maryland 20892-3706\nTel:301-435-4596\nFax:301-480-5763\nEmail:shengz@ninds.nih.gov\nLab webpage: http://intra.ninds.nih.gov/Lab.asp?Org_ID=56\n","胡秀娟研究員 02 2737 7560"]
["4","美國","National Institutes of Health (NIH)","Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS)","Study cortical processes of complex sensory stimuli in common marmosets using multi-modality approaches: electrophysiology, 2-photon imaging, and functional MRI","http://intra.ninds.nih.gov","Dr. Afonso C. Silva\nSenior investigator\nCMS/LFMI/NINDS\n","Dr. Afonso C. Silva \nNIH/NINDS/LFMI/CMS\n10 Center Drive, MSC 1065\nBuilding 10, Room B1D106\nBethesda, MD 20892-1065\n (301) 402-9703 \n","胡秀娟研究員 02 2737 7560"]
["5","美國","National Institutes of Health (NIH)","Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS)","Molecular mechanisms underlying synapse development and the regulation of synaptic transmission","http://intra.ninds.nih.gov","Wei Lu, Investigator","Luw4@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["6","美國","National Institutes of Health (NIH)","National Cancer Institute, Division of Cancer Epidemiology and Genetics","Nutritional Epidemiology Branch","http://dceg.cancer.gov/about/dceg-mission","Christian Abnet","abnetc@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["7","美國","National Institutes of Health (NIH)","National Cancer Institute, Division of Cancer Epidemiology and Genetics","Infections and Immunoepidemiology Branch","http://dceg.cancer.gov/about/dceg-mission","Anil Chaturvedi","chaturva@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["8","美國","National Institutes of Health (NIH)","National Cancer Institute, Division of Cancer Epidemiology and Genetics","Nutritional Epidemiology Branch","http://dceg.cancer.gov/about/dceg-mission","Neal Freedman","freedmanne@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["9","美國","National Institutes of Health (NIH)","National Cancer Institute, Division of Cancer Epidemiology and Genetics","Infections and Immunoepidemiology Branch","http://dceg.cancer.gov/about/dceg-mission","Allan Hildesheim","hildesha@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["10","美國","National Institutes of Health (NIH)","National Cancer Institute, Division of Cancer Epidemiology and Genetics","Genetic Epidemiology Branch","http://dceg.cancer.gov/about/dceg-mission ","Philip Taylor","ptaylor@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["11","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Molecular Pharmacology","http://ccr.cancer.gov/about/default.aspx ","Aladjem, Mirit","aladjemm@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["12","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Cell Biology","http://ccr.cancer.gov/about/default.aspx","Ambudkar, Suresh","ambudkar@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["13","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Genetics Branch","http://ccr.cancer.gov/about/default.aspx","Aplan, Peter","aplanp@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["14","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Molecular Biology","http://ccr.cancer.gov/about/default.aspx","Cheng, Sheue-yann","chengs@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["15","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Radiation Oncology Branch","http://ccr.cancer.gov/about/default.aspx ","Coleman, Norman","ccoleman@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["16","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Receptor Biology and Gene Expression","http://ccr.cancer.gov/about/default.aspx","Dalal, Yamini","dalaly@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["17","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Molecular Targets Laboratory","http://ccr.cancer.gov/about/default.aspx","Gustafson, Kirk","gustafki@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["18","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Human Carcinogenesis","http://ccr.cancer.gov/about/default.aspx","Harris, Curtis","harrisc@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["19","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Experimental Immunology","http://ccr.cancer.gov/about/default.aspx ","Hu, Yinling","huy2@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["20","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Gene Regulation and Chromosome Biology Laboratory","http://ccr.cancer.gov/about/default.aspx","Jin, Ding","jind@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["21","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","HIV DRP Retroviral Replication Laboratory","http://ccr.cancer.gov/about/default.aspx","KewalRamani, Vineet","vineet.kewalramani@nih.gov","胡秀娟研究員 02 2737 7560"]
["22","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Metabolism","http://ccr.cancer.gov/about/default.aspx","Lee, Kyung","KyungLee@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["23","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Biochemistry and Molecular Biology","http://ccr.cancer.gov/about/default.aspx ","Lichten, Michael","mlichten@helix.nih.gov","胡秀娟研究員 02 2737 7560"]
["24","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Molecular Immunoregulation","http://ccr.cancer.gov/about/default.aspx","Oppenheim, Joost","oppenhej@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["25","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Mouse Cancer Genetics Program","http://ccr.cancer.gov/about/default.aspx","Salomon, David","salomond@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["26","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Cell and Developmental Signaling","http://ccr.cancer.gov/about/default.aspx","Sterneck, Esta","sternecg@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["27","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Mouse Cancer Genetics Program","http://ccr.cancer.gov/about/default.aspx ","van Dyke, Terry","vandyket@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["28","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Cell and Developmental Signaling","http://ccr.cancer.gov/about/default.aspx","Westlake, Christopher","chris.westlake@nih.gov","胡秀娟研究員 02 2737 7560"]
["29","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Macromolecular Crystallography Laboratory","http://ccr.cancer.gov/about/default.aspx","Wlodawer, Alexander","wlodawer@nih.gov","胡秀娟研究員 02 2737 7560"]
["30","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Experimental Immunology","http://ccr.cancer.gov/about/default.aspx","Young, Howard","YoungHow@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["31","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Laboratory of Cellular and Molecular Biology","http://ccr.cancer.gov/about/default.aspx ","Zhang, Ying","ZhangYin@mail.nih.gov","胡秀娟研究員 02 2737 7560"]
["32","美國","National Institutes of Health (NIH)","National Cancer Institute, Center for Cancer Research","Gene Regulation and Chromosome Biology Laboratory","http://ccr.cancer.gov/about/default.aspx","Zheng, Zhi-Ming (Thomas)","zhengt@exchange.nih.gov","胡秀娟研究員 02 2737 7560"]

{"sheet":"Caltech","index":5,"n_rows":36,"n_cols":1,"rows_kept":36,"flags":["formulas_cached_only"]}
["Targeted Research Areas for 2013 Internship at Caltech"]
[]
["Caltech faculty members generally welcome opportunities for international collaborations based on mutual research interest. For 2011, there are four targeted research areas for collaboration, which are specified below: "]
[]
["[1] Astronomy/Astrophysics/Space Studies"]
["Astronomy, astrophysics and space studies at Caltech encompass a wide range of topics. Examples of studies range from theoretical modeling and observational verifications of cosmology to studying the Kuiper Belt in our solar system, instrumentation developments include energy sensitive single-photon counting detectors to large optical and submillimeter telescopes, and major involvement in space missions for astrophysics and planetary exploration. Facilities that Caltech researchers have access to include the Palomar Observatory (Hale 5m telescope, 1.5m Mayer telescope, 1.2m Oschin Schmidt telescope), the 10m telescopes of the W. M. Keck Observatory, the CARMA millimeter interferometer array, the 10m Caltech Submillimeter Observatory, and the telescopes of the Owens Valley Radio Observatory. Caltech researchers are involved in CMB experiments using facilities at the South Pole and on balloons. Space Astrophysics missions with major Caltech involvement include the GALEX UV imaging satellite, the Spitzer Space Telescope, the WISE all-sky survey explorer, the Herschel Space Observatory, the Planck Satellite and the Advanced Composition Explorer (ACE). "]
["The LIGO Laboratory on the Caltech campus operates the LIGO (Laser Interferometer Gravity Wave Observatory) facility. Future projects that are actively being developed at Caltech include the NUSTAR X-ray observatory and the CCAT submillimeter telescope."]
[]
["Faculty contact: Professor B. Thomas Soifer (also Chairman of the Division of Physics, Mathematics and Astronomy at Caltech), bts@irastro.caltech.edu."]
["Related website: http://www.astro.caltech.edu/. "]
[]
["[2] “Beyond Si-CMOS” nano-electronic research"]
["Current challenges in developing the technology that can go beyond the scaling limit of Si-CMOS (Complementary Metal Oxide Semiconductors) involve finding effective means of increasing the areal density of electronic devices on a chip while maintaining or even improving the performance. New materials and device concepts are necessary to facilitate such advances. Among various intensely explored paradigms, nano-electronic devices based on graphene and graphene-related materials, spintronics (spin-dependent electronics) and topological insulators have demonstrated both rich phenomena for scientific research and promising properties for beyond Si-CMOS applications. The condensed matter physics lab led by Professor Nai-Chang Yeh at Caltech has active research programs in the investigation of fundamental scientific issues associated with graphene, graphene-based electronics, spintronics and topological insulators. "]
["Additionally, the lab has forged close collaborations with other research groups (at Caltech, UCLA and UC Riverside) specializing in theoretical simulations, materials development and fabrication of nano-electronic devices. The affiliation of Professor Yeh with the Kavli Nanoscience Institute at Caltech further also makes available state-of-the-art fabrication facilities for beyond Si-CMOS nano-electronic research."]
[]
["Faculty contact: Professor Nai-Chang Yeh, ncyeh@caltech.edu. "]
["Related websites: http://www.its.caltech.edu/~yehgroup/ and http://kni.caltech.edu/."]
[]
["[3] Biophysics & Nano-biotechnology"]
["Microelectronics and nanoscience are ushering in a new generation of tools for modern biological research. These new approaches are beginning to provide unprecedented resolution of processes that open up new perspectives for understanding biological complexity.  At the heart of these exciting recent advances are technologies that enable research at the level of single molecules and individual cells, but with sufficiently high throughput to survey complex interactions that occur only in higher hierarchies in biological organisms and populations. This research is highly interdisciplinary in nature and is closely linked to Caltech’s nanoscience and nanotechnology efforts. Active areas of research at Caltech in nano-biotechnology include: systems biology, systems neuroscience, single-molecule biophysics, and nano-biotechnology for research and clinical applications.   "]
["For example, the Caltech Micromachining Laboratory led by Professor Tai exercises various MEMS and micro/nano technologies to physically fabricate integrated devices, and the research emphases include high-level system integration and hands-on fabrication of biochips, microfluidic chips, neural implants and biomedical devices. Similarly, the research lab led by Professor Roukes develops advanced nano-devices systematically for biomedical and life science applications. "]
[]
["Faculty Contacts: Professor Yu-Chong Tai, tai@mems.caltech.edu; "]
[" Professor Michael Roukes (also Co-Director, Kavli Nanoscience Institute),  roukes@caltech.edu. "]
["Related websites: http://mems.caltech.edu/; http://www.its.caltech.edu/~nano/, and http://kni.caltech.edu/"]
[]
["[4] Energy Research"]
["While much progress has been made in developing renewable energy technologies, one major goal remains elusive: bringing these efforts to the terawatt scale necessary for sustainable energy to become a viable replacement for carbon-based energy sources such as oil, coal and gas, which are limited in supply, and contribute to carbon dioxide emissions. The ability to meet the global growing demand for energy while protecting the planet's resources will require profound creativity, cutting-edge science, and new technologies that arise from a number of different fields. At Caltech, a crucible for new ideas, leaders in the fields of chemistry, applied physics, materials science, bioengineering, aeronautics, mechanical engineering and genetics are working together on innovative  approaches to capturing, amplifying, storing and converting the planet's renewable energy supplies. "]
["The Resnick Institute at Caltech strives to identify and address the most important outstanding challenges and issues in the generation, storage, transmission, conversion and conservation of energy.  The Resnick Institute provides a unique opportunity to leverage core competences in the areas of electrochemistry, biochemistry and materials, as developments in these areas converge to enable groundbreaking energy technologies. There are also opportunities for collaboration with newly-established research centers at Caltech, including energy-related micro- and nano-photonics research in the Light Material Interactions Energy Frontier Research Center, and research on semiconductor materials, heterogeneous catalysis, and photoelectrochemistry in the Joint Center for Artificial Photosynthesis."]
[]
["Faculty contact: Professor Harry Atwater (also Director of the Resnick Institute)"]
["   (haa@caltech.edu)."]
["Related websites: http://resnick.caltech.edu/ ; http://www.lmi.caltech.edu/ ; "]
["     http://solarfuelshub.org/ and http://daedalus.caltech.edu/. "]
[]
["<<回主頁>>"]

{"sheet":"Argonne","index":6,"n_rows":12,"n_cols":1,"rows_kept":12,"flags":["formulas_cached_only"]}
["Argonne National Laboratory\n2013 for Dragon Gate Program"]
[]
["  Materials and Molecular Design and Discovery: 1. Design, synthesis and control of material for energy: storage, low-power electronics, alkane oxidation, electrocatalysis; 2. In situ synthesis and characterization of bulk, film and interfacial architectures; 3. materials prediction through genetic algorithms and multiscale modeling of nucleation and growth; 4. spectro-microscopy; 5. Crystal growth and crystal growth technology; 6. Nano-photonic research"]
[]
[" Hard X-Ray Sciences: High energy x-rays have high impact in materials, biology, energy, engineering, and technology through advancing hard x-ray science using in situ techniques to explore real materials under real conditions in real time."]
[]
["      Structural biology: Structural biology contributes to the exploration of new opportunities in biology, proteomics and genomics researchwith a major focus on medicine, bio-nanomachines, and biocatalysis."]
[]
["Point of Contact:  \nNorman D. Peterson, Assistant to the Director\nArgonne National Laborotory\n9700South Cass Avenue\nArgonne, IL 60439-4832\nTel: 1-630-252-7229 office\nFax: 1-630-252-7923\nnpeterson@anl.gov"]
[]
[]
["<<回主頁>>"]

{"sheet":"哥倫比亞","index":7,"n_rows":11,"n_cols":3,"rows_kept":11,"merged":[[2,0,4,0],[2,2,4,2],[5,0,6,0],[5,2,6,2],[8,0,9,0],[8,2,9,2]],"flags":["formulas_cached_only"]}
["研習領域","研習項目介紹","研習項目聯絡人"]
["(1) Earth Sciences\n","The Lamont-Doherty Earth Observatory is a world-renowned center for research into a wide range of topics in ocean, atmosphere and earth sciences.  As part of the Columbia Earth Institute our basic research activities have become integrated into broader disciplinary efforts towards their application to societal applications such as natural hazard and risk assessment, poverty reduction, the mitigation of global warming, and the coupling of climate change to disease propagation.   Several groups at Lamont-Doherty have deep expertise in areas with particular relevance to Taiwan, including: earthquake seismology; tropical meteorology and typhoons; landslides, debris flows and floods; chemical, biological and physical oceanography. ","Faculty Contacts: \nDr. Colin Stark    cstark@ldeo.columbia.edu  -  geomorphology\nProf Adam Sobel  ahs129@columbia.edu    -  tropical meteorology\nDr. Suzana Camargo  suzana@ldeo.columbia.edu   -  tropical meteorology\nProf  Goran Ekstrom  ekstrom@ldeo.columbia.edu  - seismology\nRelated Websites:\nhttp://www.ldeo.columbia.edu/"]
["(2) Energy Frontier Research Center","The Columbia Energy Frontier Research Center was established through a grant from the Department of Energy in September of 2009 under the leadership of Prof. Tony Heinz (EE and Physics) and Prof. Louis Brus (Chemistry).  The Columbia EFRC is creating enabling technology to redefine photovoltaic efficiency through fundamental understanding and molecule-scale control of the key steps in the photovoltaic process in organic and hybrid materials.  The EFRC is systematically developing the fundamental understanding of the primary photovoltaic processes in organic and hybrid materials and it is quantitatively investigating new nanostructured materials with potential for extracting multiple electrical charges from a single absorption event. In order to understand “Charge Generation: Excitation, Separation and Extraction of Charge Carriers in Tailored Nanostructures”  ","Faculty Contacts:\nTony Heinz, Physics and Electrical Engineering (tfh3@columbia.edu)\nLouis Brus, Chemistry (rb33@columbia.edu)\nJames Yardley, Electrical Engineering (jy307@columbia.edu )\nRelated Website:\nwww.cise.columbia.edu/efrc"]
[null,"Prof. Colin Nuckolls and Prof. Louis Brus are developing a set of new, chemically well-characterized nanoscale materials.  These include new quantum dots and a set of novel chemical compounds: “molecular clusters.”  Together with Prof. Tony Heinz they are exploring the dynamics and effectiveness of fundamental processes, using modern nanoscience tools.  Prof. Latha Venkataraman and Prof. Richard Osgood are exploring the effectiveness of charge transport across interfaces through direct transport measurement, as well as through photoemission studies. "]
[null,"  In collaboration with Brookhaven National Labs, Prof. Ioannis Kymissis and others are building new materials suitable for studying the fundamental physics in heterojunction solar cell devices including new chemically tailored semiconductor materials and ordered interfaces.  In particular Prof. Philip Kim is actively exploring the use of graphene and other carbon-based conductors in solar applications.  Prof. Tony Heinz and Prof. Louis Brus are exploring experimentally new concepts in carrier multiplication in quantum dot and one-dimensional systems, while Prof. David Reichman is seeking to establish quantitative and predictive theory for novel carrier multiplication concepts."]
["(3) Integrated Circuit Design for Nanoscale Technologies","The Columbia Integrated Systems Laboratory conducts research in the development of novel designs and architectures for integrated circuits and systems.  To realize the unprecedented integration and performance opportunities of highly scaled nanometer CMOS technologies, important challenges like reduced supply voltage and higher device variability need to be mitigated using an interdisciplinary approach reaching from devices and circuits, to architectures, signal processing and applications. Researchers in the Kinget group conceive, design, lay out, send for fabrication, and experimentally verify innovative concepts to integrate analog, RF and mixed signal interfaces in standard CMOS technologies. These interfaces are the crucial link between the digital cores of system-on-chip devices and the physical world.  ","Faculty Contact:\nProf. Peter Kinget (kinget@ee.columbia.edu)\nRelated Websites:\nhttp://www.cisl.columbia.edu/kinget_group\nhttp://www.ee.columbia.edu/~kinget"]
[null,"Active areas of research are ultra-low voltage and ultra-low power RF interfaces and A/D converters; energy harvesting, conditioning and storage for \"Energy Harvesting Active Networked Tags\"; capacitor based energy storage for renewable energy sources such as photovoltaic or wind energy; multi-antenna RF systems; and pulsed RF communications for ultra-low power wireless links in biomedical applications. The group currently has strong ties to several academic research groups, companies and foundries in Taiwan."]
["(4) Multimedia Computing and Information","The multimedia research groups at Columbia University are leading the frontiers of research of next-generation search engines for multimedia (including video, music, and speech), media content understanding, security, forensics, and communication. The Digital Video and Multimedia Lab led by Chang conducts research on image retrieval, object recognition, video event analysis, and media forensics, targeting at applications of broad impact such as Internet, surveillance, biomedicine, and consumer.  Many large-scale research testbeds and corpora have been developed and disseminated worldwide. The group also plays a major role in developing international multimedia standards such as MPEG-7. The Laboratory for the Recognition and Organization of Speech and Audio (LabROSA) led by Ellis conducts research into automatic means of extracting information from various types of sound, including speech, music, and environmental sound. The groups have led major research forums and maintain close collaboration with a large number of industrial and academic institutions, including many from Taiwan. They have also established close ties with partners from other disciplines, such as Journalism, Music, Medicine, and Education.","Faculty Contacts:\nProf. Shih-Fu Chang (sfchang@ee.columbia.edu)\nProf. Dan Ellis (dpwe@ee.columbia.edu)\nRelated Websites:\nhttp://www.ee.columbia.edu/dvmm\nhttp://labrosa.ee.columbia.edu/"]
["(5) Nanoscience and Nanotechnology","The Columbia Nanoscale Science and Engineering Center (NSEC) has been developing primary understanding of charge transport in nanoscale systems since 2001.  This Center has demonstrated an extremely effective program of interdisciplinary research across the fields of chemistry, physics, electrical engineering, mechanical engineering, and applied physics and beyond.  The research program is built upon exploration of transport phenomena in single molecules, in carbon nanotubes and in two dimensional systems.  Through the scientific contributions of Profs. Philip Kim, Louis Brus, George Flynn, Tony Heinz, Jim Hone, Richard Osgood, Aron Pinczuk, Ken Shepard, Horst Stormer and others, it has established a leadership position internationally in the development and characterization of the fundamental properties of an exciting new material: graphene.  This research includes exploration of quantum interference phenomena in graphene-based devices.  ","Faculty Contacts:\nTony Heinz, Physics and Electrical Engineering (tfh3@columbia.edu)\nRonald Breslow, Chemistry (rb33@columbia.edu)\nJames Yardley, Electrical Engineering (jy307@columbia.edu )\nRelated Website: \nwww.cise.columbia.edu/nsec"]
[null,"Through collaborations amongst Prof. Tony Heinz, Prof. Louis Brus, Prof. Philip Kim, and Prof. James Hone the Columbia NSEC has developed new spectroscopic techniques for characterizing carbon nanotubes and graphene and for understanding the electronic structure and dynamics for these systems.  The center is currently extensively exploring the properties and opportunities for graphene including high frequency electronics, mechanics, and biological sensors.  The Columbia Nanocenter through Prof. Colin Nuckolls, Prof. Latha Venkataraman, Prof. Philip Kim, Prof. Ronald Breslow and others has pioneered understanding of electron conductance phenomena in single molecules – work which is changing our understanding of the role of molecules in transport and which is opening new opportunities for single molecule biological sensing and detection."]
[null,"<<回主頁>>"]

{"sheet":"NIH NIDAIRP","index":8,"n_rows":8,"n_cols":1,"rows_kept":8,"flags":["formulas_cached_only"]}
["NIH NIDA/IRP Dragon Gate Targetd Program for 2014"]
["Optogenetics is a recently developed world-reknown powerful tool for examining brain circuits and pathways for cognition, emotion, motivation, value appreciation/depreciation, and disease-related alterations in the brain and behaviors. Under the leadership of Professor Antonello Bonci, the NIDA/IRP of the NIH is one of the world leaders and pioneers in this exciting area of research."]
["NIDA Optogenetics and Transgenic Technology Core (OTTC) Facility\nTransgenic Technology:   The first part of training program will be focused on the “genetic” component  of optogenetics.   The visiting scientist/student would learn:  1)  background molecular biology for optogenetic experimentation and understand the basic principles by which it is used; 2)  safety and handling of viral vectors; 3) virological methods used to package, purify, characterize and quality control optogenetic viral vectors; 4)  in vitro and in vivo methods of delivering viral vectors for expressing optogenetic proteins.  \nOptogenetic Experimentation in Animal Models:  The second part of the training program will be directed towards using optogenetic techniques in rodent models aimed at the following:  1) manipulating neuronal activity with optics to affect behavior,  2) using optogenetics to activate or inhibit neuronal activity for brain slice electrophysiological measurements,  3) performing in vivo recordings of neuronal activity while manipulating neuronal circuits using  optogenetics.  \n"]
[]
["Point of contact: \nAntonello Bonci, M.D. Director, Intramural Program\nNational Institute on Drug Abuse\n251 Bayview Blvd\nBaltimore, MD 21224\nbharvey@mail.nih.gov\n(O) 443-740-2590\n(M) 443-462-9336\n\nBrandon K. Harvey, Ph.D.\nDirector, Optogenetics and Transgenic Technology Core (OTTC)\nIntramural Research Program\nNational Institute on Drug Abuse\n251 Bayview Blvd\nBaltimore, MD 21224\nbharvey@mail.nih.gov\n(O) 443-740-2590\n(M) 443-462-9336\n"]
[]
[]
["<<回主頁>>"]

{"sheet":"NIH-NINDS","index":9,"n_rows":7,"n_cols":3,"rows_kept":7,"flags":["formulas_cached_only"]}
["關鍵領域","2014 NIH NINDS/DIR  龍門計畫研習項目介紹","研習項目聯絡人"]
["(4) Biomedical Science and Engineering","With recent explosion of biomedical information from -omics and next generation sequencing (NGS) technology, Biomedical Informatics plays a key role to genomics and biomarker discovery and essential to the success of translational biomedical research.   NINDS intramural IT and Bioinformatics program provides expertise and resources in bioinformatics and clinical research informatics working with investigators on many exciting area of neuroscience research at NIH.                                                                                                                                 NINDS DIR Bioinformatics Section: \n\nBioinformatics Research:   The first part of training program will be focused on the core technology, tools and applications of bioinformatics for neuroscience discovery research.   The visiting scientist/student would learn:  1) wide ranges of research in bioinformatics and its tools for various types of data analysis including Arrays, ChIPs, Structural and NGS data; 2) Large scale (BIG Data) study data analysis such as CGHub, GWAS, etc.; 3) Bioinformatics applications in biomarker discovery including network pathway and biological function analyses as well as diagnostic and prognostic development.   \n\nIntegrated Biomedical Informatics:  The second part of the training program will be directed towards using biomedical informatics techniques to facilitate and promote collaboration and data sharing in clinical research aimed at the following:  1) learning the infrastructure of integrated biomedical informatics system (IBIS) supporting clinical research including clinical trials; 2) using IBIS tools such as Global Unique Identifier (GUID) for de-identification, imaging and genomics analysis, data standards and HL7 tools to facilitate large clinical studies such as research networks or centers of excellence; 3) using IBIS to create large data repository for disease research including association study, data mining and biomarker discovery. ","Yang C. Fann, Ph.D.\nDirector, Intramural IT and Bioinformatics Program\nNational Institute of Neurological Disorders and Stroke\nNational Institutes of Health\n10 Center Drive, MSC 1443\nBethesda, MD 20892\nEmail: fann@ninds.nih.gov\nPhone: 301-451-5153\nFax: 301-480-3563\n"]
["(4) Biomedical Science and Engineering","Recent advances in human induced pluripotent stem (iPS) cells and genome engineering technologies provide an unprecedented opportunity to study genes and somatic cells associated with neurological diseases by targeted genetic manipulation in patient derived iPS cells. NIH Center for Regenerative Medicine (NIH-CRM) have collected dozens of familial Parkinson Disease (PD) patients derived iPS cells, bearing mutations in SCNA, LRRK2, PARK2, and GBA. We propose to use novel high-efficient designer nucleases we developed recently to knock-in signaling pathway responsive element (SPRE)-driven luminescent reporters in patient-derived iPS cells, which will be differentiated into neurons and glia to quantitatively measure the effects of PD mutations on cell metabolism, stress response, survival/apoptosis, and cell fate maintenance. We will also employ organelle-specific and/or dopaminergic (DA) neuron-specific fluorescent reporters engineered in PD-iPS cells to study effects of PD mutations on targeted organelles and iPS-derived DA neurons. The combination of luminescent and fluorescent reporters will allow us to take advantages of ratiometric measurement of multiple reporters stabled integrated in the human genome. Finally we are interested in using the above established reporter cell lines for drug discovery by high-throughput screening chemical compounds that modulate signaling pathways, organelles, or DA neurons affected in PD patients.","Jizhong Zou, Ph.D.\nStaff Scientist\nCenter for Regenerative Medicine\n50 South Dr., Room 1146\nBethesda, MD 20892\nTel: 301-594-3119\nEmail: zouj2@mail.nih.gov\n"]
["(5) Molecular and Cellular Biology","This research proposal will be conducted in the context of the overall research plans of the Synaptic Functions Section, the Intramural Program of National Institute of Neurological Disorders and Stroke (NINDS), NIH. The laboratory focuses on investigation into the mechanisms (1) regulating mitochondrial transport in axons and its impact on synaptic function and axonal degeneration; (2) regulating neuronal autophagy-lysosomal system and its impact on mitochondrial quality control through mitophagy. We have applied molecular and cellular approaches and in vitro live neuron and in vivo imaging in a multidisciplinary systems analysis of genetically engineered mice combined with gene rescue experiments. Our long-term goal is to identify the cellular pathways for proper turnover of aged and dysfunctional mitochondria in distal axons by up-regulating the autophagy-lysosomal system. The proposed project under this NINDS/DIR Dragon Gate Targeted Program aims to understand the molecular mechanisms regulating degradation of aged and damaged mitochondria through autophagy-lysosomal system. The central hypothesis has been formulated on the basis of our published or unpublished studies in primary neuronal cultures and mouse models. We have developed a research plan by combining the strengths and expertise of the host laboratory in axonal mitochondrial transport and autophagy-lysosome function. Our rationale for pursuing this study is that our advance in understanding the regulatory mechanisms of mitochondrial transport and autophagy-lysosomal function would be very beneficial in developing novel protective and therapeutic modalities to overcome major neurodegenerative diseases associated with mitochondria dysfunction, which is thus the very essence of the mission of the NIH.                                                                                              Recent Sheng lab publications related to this proposal:\n1. Zu-Hang Sheng & Qian Cai (2012) Mitochondrial Transport in Neurons: Impact on Synaptic Homeostasis and Neurodegeneration. Nature Reviews Neuroscience 13, 77-93. \n2. Yanmin Chen and Zu-Hang Sheng. (2013). Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport. Journal of Cell Biology 202, 351-364. \n3. Tao Sun, Haifa Qiao, Ping-Yue Pan, Yanming Chen, and Zu-Hang Sheng. (2013) Mobile axonal mitochondria contribute to the variability of presynaptic strength. Cell Reports 4, 413-419. \n","Zu-Hang Sheng, PhD\nSenior Principal Investigator, \nChief of Synaptic Functions Section\nNINDS, NIH\nBuilding 35 (PNRC), Room 2B-215\n35 Convent Drive, MSC 3706\nBethesda, Maryland 20892-3706\nTel:301-435-4596\nFax:301-480-5763\nEmail:shengz@ninds.nih.gov\nLab webpage: http://intra.ninds.nih.gov/Lab.asp?Org_ID=56\n"]
["(4) Biomedical Science and Engineering","The common marmoset (Callithrix jacchus) is a New World Monkey of growing interest for systems neuroscience, with a well-developed cortical visual, auditory and somatosensory system.  The lissencephalic cortex makes most of the cortical areas accessible to optical imaging techniques and facilitate placement of electrode arrays for electrophysiology. In our recent work, we have successfully trained marmosets to lay awake in the MRI and we can routinely obtain robust fMRI responses to somatosensory, auditory and visual stimulation. In particular, we are strongly interested in using fMRI, optical imaging and electrophysiology to understand the spatiotemporal characteristics of neurovascular coupling and to better understand the organization of cortical sensory processing. For example, we recently found multiple face and body selective patches in the extra-striate visual areas, including V3, V4/TEO, V4t, and TE, using both fMRI and subdural electrocorticography (ECoG). These exciting results show that fMRI has enough spatial resolution to resolve fundamental cortical domains. Next, we plan to use single unit recording and two-photon laser scanning microscopy to further investigate how the neural populations in these patches encode different visual stimuli, and to investigate how marmosets’ cortical visual system processes naturalistic visual stimuli at different spatial and temporal scales. We are seeking talented neuroscientists, biomedical engineers and/or physicists interested in using optical imaging, electrophysiology, and functional MRI, to understand neurophysiological mechanisms of cortical sensory processing. The lab provides a state-of-the-art 7T/310 mm horizontal animal magnetic resonance imaging scanner, a state-of-the-art two-photon laser scanning microscope, and electrophysiology and other optical imaging instrumentation for combined multi-electrode recording and intrinsic signal imaging. Candidates with experience in imaging and/or electrophysiology are particularly encouraged to apply.","Dr. Afonso C. Silva, Ph.D.\nChief, Cerebral Microcirculation Unit \nSenior Investigator, NINDS Intramural Research Program\n49 Convent Drive, MSC 1065\nBuilding 49, Room 3A72\nBethesda, MD 20892-1065\n Tel: +1(301) 402-9703 \nFax: +1(301) 480-2558\nE-mail: SilvaA@ninds.nih.gov\nhttp://www.neuroscience.nih.gov/Lab.asp?Org_ID=510\n"]
["(5) Molecular and Cellular Biology ","Essentially all brain functions rely on proper synaptic transmission between neurons. My lab is interested in how synapses are constructed during development and how the strength of synaptic communication is regulated in mature neurons. We mainly utilize rodent hippocampus as our research model system. To study these questions, we employ molecular and genetic manipulations to perturb expression of key molecules involved in synapse development and function in primary neuronal cultures, organotypic brain slice cultures and intact animals. We combine whole-cell electrophysiological recordings with cell biological, imaging, biochemical and behavioral approaches to study the mechanisms underlying the role of these molecules in synaptic development and function. Currently we focus on the role of glutamate receptors in early synapse development and molecular mechanisms for the regulation of AMPA receptor-mediated synaptic transmission.","Wei Lu, Ph.D.\nInvestigator, NINDS, NIH\nEmail: luw4@mail.nih.gov\nPhone: 301-594-6207\n"]
[null,"<<回主頁>>"]

{"sheet":"NIH-NCI","index":10,"n_rows":29,"n_cols":3,"rows_kept":29,"flags":["formulas_cached_only"]}
["關鍵領域","2014 NIH NCI  龍門計畫研習項目介紹","研習項目聯絡人"]
["(4) Biomedical Science and Engineering","Etiologic studies of esophageal and gastric cancer\nDeveloping exposure markers for nutritional and toxic elements for use in epidemiologic studies\nOral health and cancer\nEarly detection methods for esophageal squamous cell carcinoma in high-risk populations\nMember of the DCEG Upper Gastrointestinal Cancers Research Group","Christian C. Abnet, Ph.D, M.P.H. Investigator                                                                                     abnetc@mail.nih.gov                                                                                                                            240-276-7213"]
["(4) Biomedical Science and Engineering","My research focuses on elucidating the role of infections, inflammation, and immunosuppression in cancer etiology.\nInfections and inflammation in the etiology of lung cancer\nInfections and inflammation in the etiology of head and neck cancers\nThe role of immunosuppression and immune activation in cancer etiology","Anil Chaturvedi, Ph.D. Investigator chaturva@mail.nih.gov                                                                 240-276-7193"]
["(4) Biomedical Science and Engineering","Diet, energy balance, and liver cancer\nGastrointestinal conditions and hormones in cancer\nThe role of tobacco and tobacco products in cancer and disease\nMember of the DCEG Upper Gastrointestinal Cancers Research Group","Neal D. Freedman, Ph.D., M.P.H. Investigator freedmanne@mail.nih.gov                 240-276-7195"]
["(4) Biomedical Science and Engineering","We are conducting large-scale population studies to investigate exogenous and host factors involved in the pathogenesis of DNA virus-related tumors. Two groups of tumors are under investigation: female gynecological cancers linked to HPV and nasopharyngeal cancer linked to EBV. Non-viral factors involved in the pathogenesis of HPV and EBV-related cancers are also being examined, since infection alone is rarely sufficient for the development of cancer. We are also involved in the evaluation of the long-term impact of HPV vaccination and in elucidating immunological mechanisms involved in long-term vaccine efficacy. To this end, Dr. Hildesheim is the lead NCI investigator on a 7,465 women community-based HPV-16/18 Vaccine Trial in Costa Rica.","Allan Hildesheim, Ph.D. Chief           hildesha@mail.nih.gov                                                                   240-276-7101"]
["(4) Biomedical Science and Engineering","Upper Gastrointestinal Cancer Research\nMy current primary research interest is in the development of prevention strategies for cancers of the upper gastrointestinal (UGI) tract, including esophageal and gastric cancers, although I retain interest in prevention of other cancers, including prostate, lung, and breast. My work has involved a variety of different research approaches, including the conduct of cancer prevention trials, early detection studies, etiologic studies, laboratory-based molecular research, and clinical nutrition studies.","Philip R. Taylor, M.D., Sc.D. Senior Investigator                                                                                  ptaylor@mail.nih.gov                                                    240-276-7235"]
["(4) Biomedical Science and Engineering","The broad goal of the DNA Replication Group at the Laboratory of Molecular Pharmacology is to understand cellular networks that signal to and from chromatin to modulate DNA replication. Since many regulatory feedback pathways are deregulated in cancer cells, the results of these studies will help our understanding of cancer biology and elucidate how normal and cancer cells regulate DNA replication. ","Mirit I. Aladjem, Ph.D. Head, DNA Replication Group\nSenior Investigator                                                             aladjemm@mail.nih.gov                             301-435-2848"]
["(4) Biomedical Science and Engineering","Project Title: Biochemistry of Multidrug Transporters \nATP-binding cassette (ABC) transporters such as P-glycoprotein (Pgp, ABCB1), the multidrug resistance-associated protein 1 (MRP1, ABCC1), and ABCG2 (MXR, BCRP), which function as ATP-dependent efflux pumps, play an important role in the development of multidrug resistance (MDR) in most cancers. Our current goals are to determine the mechanisms of action of multidrug resistance-linked ABC transporters including Pgp and ABCG2. We are addressing these questions: a) What is the molecular mechanism of the polyspecificity of Pgp? b) How do substrate binding and ATP sites interact? c) How is the energy from ATP hydrolysis used for drug transport? Our long-term goal is to elucidate the role of ABC drug transporters in the development of MDR in cancers and facilitate new therapeutic strategies. \nCurrent work: \n1. Elucidation of the catalytic cycle of ATP hydrolysis and transport pathway of Pgp and role of conserved motifs in the ATP-binding cassette. \n2. Development of potent non-toxic small molecule modulators/inhibitors of ABC transporters. \n3. Resolution of the three-dimensional structure of human Pgp. \n4. Role of intracellular loops 1 and 3 in folding and stability of human Pgp: \nThese studies should provide insights into the mechanism of action and regulation of these transporters and aid in the development of strategies to increase the efficiency of chemotherapy to treat cancer.","Suresh V. Ambudkar, Ph.D. Head, Transport Biochemistry Section\nDeputy Laboratory Chief                                                   ambudkar@mail.nih.gov                           301-402-4178"]
["(4) Biomedical Science and Engineering","A large number of hematologic malignancies are associated with non-random, recurrent chromosomal translocations. These translocations typically either activate latent proto-oncogenes or create novel fusion genes. Our approach to studying leukemia in general is as follows: \n1) Identify and clone the genes located at translocation breakpoints. \n2) Test the oncogenic potential of these genes in animal models. \n3) If the animals develop leukemia, or other hematologic malignancy, study the process of malignant transformation over time (ie, can occult, pre-malignant lesions be identified in clinically healthy animals). \n4) Identify collaborating events, ie genes and pathways that, when abrogated, can collaborate with the gene of interest. \n5) Use the animal model for pre-clinical testing of cancer treatment modalities. ","Peter D. Aplan, M.D. Head, Leukemia Biology Section\nSenior Investigator                                                 aplanp@mail.nih.gov                               301-435-5005"]
["(4) Biomedical Science and Engineering","Thyroid Hormone Receptor Mutants: Molecular Actions and Roles in Disease \nThyroid hormone receptors (TRs) mediate the biological activities of the thyroid hormone (T3) in growth, development, and differentiation and in maintenance of metabolic homeostasis. There are two TR genes, alpha and beta, located on human chromosomes 17 and 3, respectively. Alternative splicing of the primary transcripts gives rise to four major T3-binding isoforms: alpha 1, beta 1, beta 2, and beta 3. The expression of TR isoforms is tissue-dependent and developmentally regulated. \n\nGiven the critical roles of TRs, it is reasonable to expect that mutations of TRs would have deleterious consequences. Indeed, mutations of the TRbeta gene are known to cause a human genetic disease, resistance to thyroid hormone (RTH). However, whether mutations of the TRbeta gene can cause other human diseases was not clear. We therefore have created and exploited genetically engineered mice as models to understand the in vivo actions of mutated TRs and their roles in human disease and to gain new insights into the understanding of molecular mechanisms of wild-type TR actions in vivo. Moreover, these mouse models are being used to develop potential treatment strategies for diseases. ","Sheue-yann Cheng, Ph.D. Head, Gene Regulation Section\nSenior Investigator                                                                       chengs@mail.nih.gov                                        301-496-4280"]
["(4) Biomedical Science and Engineering","Dr. Coleman's current research program is based on long-standing interest in the tumor-induced and radiation-induced stress responses. The long-term focus is on developing molecular targeted radiation therapy. An overarching concept is of radiation therapy as 'focused biology' wherein radiation is described by the molecular events produced rather than by just the dose in Gray. \nBased on long-standing interest in NSAIDs and COX inhibitors, a focus of the laboratory over the last few years has been studying the effects of drugs and molecular-targeted agents at clinically relevant concentrations. Using COX inhibition as an example, we have demonstrated that the gene expression profile is very different when NSAIDs and COX2 inhibitors are used at high versus a low, clinically relevant concentration and also that siRNA is different than any of the drug conditions. This emphasizes the critical importance of using clinically relevant concentrations for preclinical mechanism and biomarker studies. That the NSAIDs induced a cardiovascular gene profile in both tumor and normal tissue (Note- this limited clinical utility of COX-2 inhibitors not discovered until post-market evaluation) suggests that it might be possible to predict normal tissue toxicity of drugs using molecular profiling, an observation being pursued. \nA new program underway that began in collaboration with Dr. Jim Mitchell is that of radiation inducible molecular targets that builds on our 'focused biology' approach in which radiation can create molecular changes within the radiation field. These changes may be useful in inducing or enhancing cell killing by drugs and molecular-target agents and would be a novel therapeutic approach. This builds on both the non-oncogene addiction and synthetic lethality models and may be a unique use of radiation therapy. Our first publication on this topic included gene expression changes and further manuscripts have been accepted, under review and in preparation studying miRNA and phosho- protein changes with single and fractionated doses. In this 'nano-IMRT' concept, the radiation dose and fractionation would be selected based on molecular target activation. ","C. Norman Coleman, M.D. Head, Experimental Therapeutics Section\nSenior Investigator                                                 ccoleman@mail.nih.gov                                       301-496-5457"]
["(4) Biomedical Science and Engineering","Current goals of the lab are to elucidate 1) how CenH3 nucleosome structure varies through the cell cycle, 2) how assembly and disassembly kinetics influence the centromeric chromatin fiber accessibility and uniformity, 3) how the global chromatin fiber's three-dimensional arrangement and structure is altered when the individual nucleosomes that make up the fiber are replaced by CenH3 or other histone variants in colorectal tumors, 4) functional and epigenetic consequences of histone variant invasion of ectopic loci, and 5) whether the distinctive features we observe in fly and human are conserved in other species. Our collaborative projects range from developing new atomic force microscopy applications to enable fluorescent single molecule recognition within native chromatin, analyzing the structure of human artificial chromosomes, to mapping chromatin domains at fragile regions in human chromosomes. ","Yamini Dalal, Ph.D. Head, Chromatin Structure and Epigenetic Mechanisms\nInvestigator                                                           dalaly@mail.nih.gov                                                301-496-9247"]
["(4) Biomedical Science and Engineering","The NCI maintains a repository of natural product extracts that is the largest and most diverse in the world. These extracts, derived from terrestrial, marine and microbial organisms, constitute a unique source of chemical diversity for the discovery of compounds that can interact with specific molecular targets associated with human cancer. We are utilizing high throughput screening technologies to help identify compounds and extracts that can specifically interact with or modulate the function of selected biochemical targets or processes. Bioassay-guided chemical fractionation of natural products extracts is employed to isolate and purify the individual bioactive compounds. Identification and structural characterization of these compounds provides new structural classes or molecular scaffolds for the development of potential drug leads or biological probes which can interact with the desired molecular target. In addition to extensive spectroscopic analyses, our efforts include rigorous evaluation of a new compound's potency, molecular target specificity, and mode of action.","Kirk R. Gustafson, Ph.D. Head, Natural Products Chemistry Group\nSenior Scientist                                                                          gustafson@ncifcrf.gov                       301-846-5197"]
["(4) Biomedical Science and Engineering","Our continuing research projects utilize an integrative biology and translational strategy that addresses facets of the NCI strategic objectives: (a) Understand the causes and mechanisms of cancer; (b) Improve early detection and diagnosis; (c) Understand the factors that influence cancer outcomes; and (d) Overcome cancer health disparities. (The NCI Strategic Objectives; the Nation's Investment in Cancer Research, FY2009) As described in the overview of LHC, our strategy and strength is to conduct laboratory-epidemiological investigations and to mentor young investigators.","Curtis C. Harris, M.D. Head, Molecular Genetics and Carcinogenesis Section\nLaboratory Chief                                                                           curtis_harris@nih.gov                                           301-496-2048"]
["(4) Biomedical Science and Engineering","The research interests of The Inflammation and Tumorigenesis Section at the LEI are to understand the physiological activities of IKKα in skin tumorigenesis and inflammation and reveal the mechanisms of how IKKα regulates these function by using genetic animal models, including Ikkα conditional knockout, Ikkα kinase inactive knockin, and IKKα transgenic mice, and molecular biology approaches.","Yinling Hu, Ph.D. Head, Inflammation and Tumorigenesis Section\nInvestigator                                                           huy2@mail.nih.gov                              301-846-1478"]
["(4) Biomedical Science and Engineering","Regulation of transcription is a key step in controlling gene expression in all living cells and is important in bacterial pathogenesis leading to human disease and/or cancer. The basic structure-function of RNA polymerase (RNAP) is conserved throughout evolution. My basic research program studies RNAP and transcriptional regulation in bacterial growth and stress responses using cutting edge techniques and interdisciplinary approaches including systems biology perspectives. A central issue of my research is to understand the relationship of transcription and structure of bacterial chromosome (nucleoid) - specifically, how transcription machinery is spatially organized and positioned in nucleoid in response to environmental cues and how the organization of nucleoid is influenced by RNAP in fast-growing cells and during stress responses. We focus on the Escherichia coli model system and also extend our basic research to human pathogenic bacteria including Helicobacter pylori that is classified as a Group 1 carcinogen. ","Ding J. Jin, Ph.D. Head, Transcription Control Section\nSenior Investigator                                                 jind@mail.nih.gov                               301-846-7684"]
["(4) Biomedical Science and Engineering","Examination of Virus-Host Interactions at Molecular, Cellular, and Animal Levels to Better Understand HIV Immunopathogenesis and the Development of Antiviral Resistance \nThe Model Development Section (MDS) seeks to further basic science understanding of HIV-1 replication, cell biology, and immunology as well as translate basic research findings to develop model systems that more faithfully mimic human immunodeficiency virus (HIV) infection in vivo. \nCurrent projects in the MDS include: \n(1) Understanding how HIV-1 exploits cell biological mechanisms to further virus replication. \n(2) Identification of innate intracellular mechanisms that counteract HIV-1 replication. \n(3) The development of improved nonhuman primate models to study HIV-1 pathogenesis and persistence. \nPlease visit the MDS publications page to see our progress in these various research areas. \nVisiting scientists, graduate students, or postdoctoral candidates interested in the possibility of performing research studies in the MDS should contact Dr. Vineet KewalRamani (vineet@mail.nih.gov). Information for other postdoctoral positions in the HIV DRP can also be found on the Recruitment web page.","Vineet N. KewalRamani, Ph.D. Head, Model Development Section\nSenior Investigator                                                 vineet.kewalramani@nih.gov                                301-846-1249"]
["(4) Biomedical Science and Engineering","The general research theme of the Chemistry Section is to understand the mechanisms that regulate various mitotic events and cellular proliferation. Our primary focus is to understand the function of mammalian polo-like kinase 1 (Plk1), a critical mitotic kinase that is upregulated in ~ 80% of human cancers. A growing body of evidence suggests that Plk1 plays a critical role in numerous mitotic events and cellular proliferation. As such, down-regulation of Plk1 activity results in mitotic catastrophe and apoptotic cell death, whereas constitutive expression of Plk1 induces oncogenic focus formation and tumors in nude mice. Plk1 has been suggested as a biomarker for several types of human cancers (breast, ovarian, non-small cell lung, head/neck, colon, endometrial and esophageal carcinomas, and leukemias) and is considered an important potential target for anti-cancer therapy. To steer a drug discovery program based on strong basic science and to fulfill the mission of the NCI in eliminating suffering and death from cancer, we are investigating the mechanisms of how Plk1 deregulation leads to the development of cancers in humans. To this end, we have focused on isolating novel Plk1 substrates and binding proteins, two of which have been identified as a kinetochore protein, PBIP1, and a centrosomal protein, hCenexin1. Both of these proteins interact with the polo-box domain (PBD) of Plk1, which is essential for targeting the catalytic activity of Plk1 to specific subcellular structures. The physiological significance of these interactions is currently under investigation. Intriguing early results indicate that Plk1-dependent PBIP1 phosphorylation at T78 induces a high affinity interaction between PBIP1 and Plk1 PBD and as a result p-T78 PBIP1-dependent Plk1 recruitment to the mitotic kinetochores. Absence of the PBIP1-Plk1 interaction leads to chromosome missegregation and aneuploidy, suggesting that PBIP1-dependent Plk1 recruitment to the kinetochores is critical for maintaining chromosome stability. Paradoxically, fully activated Plk1 induces PBIP1 degradation in early mitosis, although the mechanism and the significance of this event are yet to be investigated. Intriguingly, a phospho-T78 peptide specifically bound to Plk1, but not to the related Plk2 or Plk3. Further investigation on the nature of the p-T78 peptide-Plk1 PBD interaction will be important to define the structural determinants for the PBD binding, leading to the isolation and design of anti-Plk1 PBD inhibitors and anti-Plk1 therapeutic agents. ","Kyung S. Lee, Ph.D. Head, Chemistry Section\nSenior Investigator                                                 kyunglee@pop.nci.nih.gov                                     301-496-9635"]
["(4) Biomedical Science and Engineering","Research : (1) Mechanism and Control of Meiotic Recombination (2) Initiation of meiotic recombination  (3) Partner choice in meiotic recombination (4) Regulation of meiotic recombination intermediate formation and resolution  (5) Recombination intermediate resolution in the mitotic cell cycle ","Michael Lichten, Ph.D. Head, Microbial Genetics and Biochemistry Section\nSenior Investigator                                                 mlichten@helix.nih.gov                                          301-496-9760"]
["(4) Biomedical Science and Engineering","The Role of Cytokines in Host Defense and Repair \nBased on our findings that the antimicrobial defensins are chemotactic for host cells that express chemokine receptors (CCR6 or CCR2) our laboratory has changed its emphasis considerably from studies of chemokines to studies of chemokine mimics and other endogenous molecules that are rapidly released by cellular degranulation or cell necrosis in response to infectious or injurious danger signals. These molecules rapidly initiate host defense based on their interaction with chemotactic as well as activating receptors on host cells. We have termed them 'alarmins' based on their capacity to rapidly mobilize and activate innate as well as subsequent adaptive host immune defense mechanisms. This alarmin concept was conceived based on our earlier studies of antimicrobial proteins such as defensins and cathelicidin (LL37) that we identified as having the capacity to use both chemoattractant receptors on as well as activating receptors on host antigen-presenting cells. This idea led us to identify other antimicrobial proteins as having similar properties including eosinophil-derived neurotoxin (EDN), lactoferrin, granulysin, high mobility group (HMG) box 1 protein (HMGB1), and more recently HMG nucleosome-binding protein 1 (HMGN1). All of the alarmins identified so far have the capacity to activate dendritic cells and promote adaptive immunity. Since radiotherapy, chemotherapy and growing tumors themselves certainly cause extensive tissue injuries and increased susceptibility to infections, they undoubtedly induce the release of alarmins. Consequently, alarmins participate in the host response to cancer, and they can also potentially be used as immunoadjuvants in tumor vaccines. The alarmin concept has enabled us to identify a previously unidentified subset of Danger Associated Molecular Patterns (DAMPs) with the capacity to rapidly mobilize and activate host defense with potential anti-tumor activities. ","Joost J. Oppenheim, M.D. Head, Cellular Immunology Group\nLaboratory Chief                                                   oppenheJ@mail.nih.gov                                           301-846-1551/1347"]
["(4) Biomedical Science and Engineering","Role of EGF-Related Peptides in the Pathogenesis of Breast and Colon Cancer \nThe Tumor Growth Factor Section is engaged in studying the biology of novel epidermal growth factor (EGF)-related peptides such as amphiregulin (AR), heregulin (HRG), and cripto-1 (CR-1) and their relationship to the pathogenesis of breast and colorectal cancer. This laboratory has found that several of these growth factors such as TGF-alpha, AR, and CR-1 are differentially overexpressed in a majority of primary human breast and/or colorectal tumors and in premalignant lesions in these tissues relative to normal, noninvolved mammary or colonic epithelium. We have found that the expression of TGF-alpha, AR, and HRG can be upregulated by specific oncogenes such as an activated c-Ha-ras gene or by an overexpressed c-erb B-2 gene and can function as autocrine growth factors for these oncogene-transformed mammary and colonic epithelial cells. We have also found that expression of TGF-alpha and AR can be enhanced by estrogens and can be decreased by antiestrogens such as tamoxifen in malignant human mammary epithelial cells. ","David S. Salomon, Ph.D. Head, Tumor Growth Factor Section\nSenior Investigator                                                  salomond@mail.nih.gov                                         301-228-4770"]
["(4) Biomedical Science and Engineering","The C/EBPδ transcription factor: Dr. Jekyll and Mr.Hyde in Mammary Tumor biology                                Our current research is designed to elucidate the mechanisms that underlie the dual functions of C/EBPδ in tumorigenesis and that determine the switch between these functions. Specifically, we are investigating the molecular mechanism(s) that determine whether C/EBPδ acts as a tumor suppressor or tumor promoter within mammary epithelial cells. Toward this aim, we focus on hypoxia and inflammation as mediators of epithelial-mesenchymal transition and cancer cell stemness. We are also investigating the contributions of C/EBPδ functions in the tumor microenvironment on mammary tumor development. Towards this goal, we have recently developed mice with a conditional knockout allele of C/EBPδ. Through ChIP-Seq and mRNA-Seq approaches we have identified several new target genes whose expression correlates with better outcome for breast cancer patients, and we are investigating their functions in breast tumor cells. \nCollectively, these approaches will provide deeper insight into the molecular mechanisms that modulate mammary epithelial cell biology and may allow us to better understand the complexity and diversity of cellular processes in normal development and breast cancer. ","Esta Sterneck, Ph.D. Head, Molecular Mechanisms in Development Group\nSenior Investigator                                                                         sternecg@mail.nih.gov                    301-846-1471"]
["(4) Biomedical Science and Engineering","The Van Dyke laboratory (Cancer Pathways and Mechanisms Section) studies the mechanisms of cancer etiology at many levels (genetic, molecular, cell, organ, organism). Genetically engineered mice (GEM) are used to examine cause/effect relationships in initiation and progression of disease within the natural microenvironment. In vivo studies of de novo tumorigenesis are coupled with cell culture and transplantation studies, and modern technologies are applied to the problem (e.g., genetic and cellular mouse manipulation, global molecular assessment and live animal imaging). With an interest in the cell specificity, we have examined tumorigenesis in multiple tissue and cell types including mammary, prostate, ovarian, and choroid plexus epithelia and astrocytes. Roles of tumor suppressors, pRb, p53 and Pten, have been identified genetically, with additional mechanistic understanding in several cases. We have also contributed to the study of mitotic regulation with the aim to determine role(s) in cancer. Currently the lab focuses on basic mechanistic studies of high grade astrocytoma and prostate cancer. The cross comparison of disease initiation and progression in these models, often driven by similar pathways/networks, relative to our understanding of the cognate human cancer, is used to develop and query hypotheses of etiology. Deep analyses of specific biological problems in cancer focus on etiology mechanisms invasion, metastasis (prostate cancer) and target cell type(s). Finally, these studies have produced highly penetrant preclinical cancer models useful for translation to human studies, including biomarker and therapeutic discovery and small animal imaging.","Terry A. Van Dyke, Ph.D. Head, Cancer Pathways and Mechanisms\nSenior Investigator                                                  vandyket@mail.nih.gov                                   301-846-1988"]
["(4) Biomedical Science and Engineering","One focus of the lab is to understand the molecular mechanism of the Rab11-Rab8 cascade important for primary cilium formation, termed ciliogenesis, and apical membrane formation in polarized cells. Rab8 was previously identified as a regulator of ciliogenesis following the discovery that Rabin8, the Rab8 GEF, associates with the BBSome, a core group of Bardet-Biedl syndrome (BBS) proteins. The primary cilium is present on most cells and defects associated with ciliary signaling, including the Sonic hedgehog pathway, have been linked to BBS and a growing list of genetic diseases and certain cancers. Our prior work suggests that ciliogenesis initiation is preceded by the signaling-dependent binding of Rabin8 to Rab11. Rabin8 is transported via Rab11-recycling endosomes to the centrosome where Rab8 is activated to assemble the primary cilium membrane. We have developed advanced microscopy techniques to monitor in real-time the assembly of the primary cilium - a process completed in approximately 100 minutes. Cell biology, proteomics, biochemistry and genetics approaches are being used to indentify and characterize associated factors in this pathway. As an example of this approach, mass spectrometry analysis of purified LAP (localization and affinity purification)-tagged Rabin8 was used to identify interactions with the TRAPPII complex, found to be required for Rabin8 centrosomal targeting and ciliogenesis. We are also investigating the roles of these and other membrane transport pathways in the sorting of receptors to the cilia and in the transmission of ciliary signals within the cell. ","Christopher J. Westlake, Ph.D. Head, Membrane Trafficking and Signaling\nInvestigator                                                           westlakecj@mail.nih.gov                                             301-846-7594"]
["(4) Biomedical Science and Engineering","Our Section investigates the relationship between protein structure and function, mainly by the technique of high-resolution X-ray diffraction. Some of the areas of interest are directly involved in elucidating structural features of the molecules that could explain their importance to understanding cancer and AIDS, but we are also active in the development of methods for protein crystallography.  (1) Crystallographic studies of proteases and their inhibitors (2) Cytokines and cytokine receptors  (3) Lectins with Antiviral Activity    ","Alexander Wlodawer, Ph.D. Head, Protein Structure Section\nLaboratory Chief                                                   wlodawer@nih.gov                                                 301-846-5036\n"]
["(4) Biomedical Science and Engineering","Regulation of Cytokine Gene Expression \nThe Cellular and Molecular Immunology Section studies the control of gene expression during the development and maturation of the cellular immune system in mediating antitumor and anti-inflammatory immune responses. The general goals of this section are to use cellular and molecular approaches to investigate the consequences of persistent exposure to IFN-gamma alters host physiology. The specific aim of the Cellular and Molecular Immunology Section is to study how chronic IFN-gamma expression influences immune system development and maturation. To approach this question, we have generated a novel mouse model where a portion of the 3' untranslated region of the mRNA has been changed and this will now permit us to understand the role of this region on IFN-gamma expression. We have backcrossed this genetic change onto the murine C57BL/6 and Balb/c genetic backgrounds and as a consequence have developed new mouse models for lupus and aplastic anemia. These mice are characterized by low but chronic Interferon-gamma expression. As a result there is persistent upregulation of IFN-gamma inducible genes, resulting in the development of autoimmunity. Overall, our studies represent a cellular and molecular analysis of the regulation of cytokine gene expression in lymphoid cells and on the host and provide a basis for developing a more complete understanding of the effects of IFN-gamma expression during the pathogenesis of autoimmune disease, cancer and infection. \n\nAn additional project in the lab focuses on the introduction of target antigens coated onto probiotic bacteria, for the purpose of determining if intestinal mucosal exposure of these antigens can lead to a protective immune response. ","Howard A. Young, Ph.D. Head, Cellular and Molecular Immunology Section\nDeputy Laboratory Chief                                             younghow@mail.nih.gov                                    301-846-5743/5700"]
["(4) Biomedical Science and Engineering","Molecular mechanisms of TGF-beta signaling pathway \nTGF-β and its related factors regulate a broad range of cellular functions, including proliferation, differentiation, apoptosis, migration and adhesion, and play very important roles in cancer and many other diseases. Our research has focused on three aspects of TGF-β signaling in an attempt to gain further appreciation of its regulation, mechanisms of action and function in development and tumorigenesis. \n\nThe first area of our research focused on the regulation of TGF-β signaling modulators by post-translational modification that translate quantitative difference in ligand concentration into proportional transcriptional output, particularly the ubiquitin modification catalyzed by Smurf1 and Smurf2, which are HECT-domain E3 ligases. Resorting to mouse genetic approaches, we generated knockout alleles of both Smurf1 and Smurf2 genes to address their roles under physiological conditions. We found that Smurf1 and Smurf2 have both common and unique functions during embryogenesis and in maintaining adult physiological homeostasis. Our earlier work on characterizing Smurf1 knockout mice revealed a novel function of Smurf1 in the regulation of osteoblast function and bone homeostasis (Cell 2005), suggesting that targeting Smurf1 may prove to be an effective strategy for treating age-related bone losses in osteoporosis. Our recent work on characterizing Smurf2 knockout mice clarified contradictory reports in the literature about Smurf regulation of TGF-β signaling by showing that Smurf2 indeed has an inhibitory role, but it does so by attenuating Smad3 activity through mono-ubiquitination rather than promoting its degradation as previously reported (EMBO J 2011). Our study also led to an unexpected discovery of a previously unrecognized function of Smurf2 as a tumor suppressor that normally maintains genomic stability by controlling epigenetic landscape of histone modifications via RNF20 (Nature Medicine 2012). ","Ying E. Zhang, Ph.D. Senior Investigator                       zhangyin@mail.nih.gov                               301-496-6454"]
["(4) Biomedical Science and Engineering","Viral RNA Splicing and Oncogenesis \nThe Zheng laboratory studies protein-RNA interactions and their subsequent consequences in oncogenic DNA tumor virus infection. More specifically, the laboratory focuses on how protein-RNA interactions regulate gene expression of high-risk human papillomaviruses and Kaposi sarcoma-associated herpesvirus. In particular, this study aims to understand how RNA splicing and small regulatory RNAs regulates viral and cellular gene expression during oncogenic virus infection. Our long-term goal is to develope a series of RNA-based therapeutic approaches to control viral or cellular gene expression and to identify some biomarkers for clinical diagnosis and prognosis. ","Zhi-Ming Zheng, M.D., Ph.D. Head, Tumor Virus RNA Biology Section\nSenior Investigator                                                 zhengt@exchange.nih.gov                                        301-594-1382 or 1207"]
[null,"<<回主頁>>"]

{"sheet":"Harvard University","index":11,"n_rows":5,"n_cols":1,"rows_kept":5,"flags":["formulas_cached_only"]}
["Dragon Gate Program"]
["GENERAL EXAMINATION FIELDS\n\nModern Chinese Literature\nThe modern Chinese literature field includes literary works, genres, and authors from the late Qing to the present. Candidates are expected to have broad knowledge of the historical, intellectual, and cultural issues of the modern period, as well as a good command of the theoretical and methodological issues involved in the study of this field. The exam could be tailored to include a special emphasis on colonial and modern Taiwanese literature, or Asian American and diasporic literatures.\n \nPrimary Research Language\nFluency in modern Chinese, ability to read classical. Candidates who choose to focus on Taiwanese literature as part of their field need to also demonstrate a high level of reading proficiency in Japanese. \n"]
["Point of Contact:  \nDavid Der-wei Wang\nEdward C. Henderson Professor of Chinese Literature\nDepartment of East Asian Languages and Civilizations\nAddress:2 Divinity Ave, Cambridge, Middlesex, Massachusetts 02138\nTel: (617) 496-0925 \nEmail:dwang@fas.harvard.edu"]
[]
["<<回主頁>>"]